Term
Name the 4 types of infections classified as upper respiratory tract infection. |
|
Definition
- Pharyngitis - Sinusitis - Otitis media - Bronchitis (is lower respiratory tract infection, but it is caused by similar organisms found in URTI) |
|
|
Term
Name 5 common organism that causes pharyngitis. •Which is most common in children? |
|
Definition
- - Group A beta-hemolytic strep (strep pyogenes) – most common! Group A strep is more common in children!!
- - Group C and G strep 4th most common
- Viruses (rhinovirus) are 3rd most common and produce most of acute cases - Other viruses include herpes, influenza virus, coronavirus and adenovirus
- Others organisms - Arcanobacterium hemolyticus, corynebacterium dipthariae, neisseria gonorrhea, mycoplasma species, chlamydia species.
- “unknown” organisms account for 30% of infections
|
|
|
Term
Acute pharyngitis is caused by ____ |
|
Definition
|
|
Term
What is the difference between acute and chronic pharyngitis? |
|
Definition
Acute pharyngitis is caused by viral infection, while chronic cases are caused by bacterial infection.
|
|
|
Term
How is pharyngitis diagnosed: 2 methods.
· Which is the gold standard?
· Which is commonly used? |
|
Definition
|
|
Term
The 2 most common site of infection of sinusitis are? |
|
Definition
Maxillary and ethmoid sinuses |
|
|
Term
Difference between viral and bacterial sinusitis. |
|
Definition
- Viral infection are shorter in duration (5-7 days) and bacterial infection is (2 weeks or more). They can cause superimpose infection. |
|
|
Term
Organisms that cause sinusitis. •Which is the most common in children? Which is most common in adults? |
|
Definition
-Bacteria sinusitis are more common in children ex. - Strep pneumoniae
- Staph aureus
- Strep pyogenes
- G negatives
- H. influenza
- superimposed H. influenza and strep pneumo infection
- moraxella catarrhalis
- anaerobes (peptostreptococcus, fusobacterium)
|
|
|
Term
If sinusitis is chronic (>12 weeks), then expect more ___, ___ and ___. |
|
Definition
|
|
Term
|
Definition
|
|
Term
THis URTI is most common in children. |
|
Definition
|
|
Term
Differentiate between recurrent acute otitis media, persistent otitis media and chronic suppurative otitis media. |
|
Definition
|
|
Term
Give 2 reasons why more children suffer from otitis media than adults. |
|
Definition
|
|
Term
What are 3 functions of Eustachian tube? |
|
Definition
|
|
Term
4 common pathogens in otitis media. which is the most common cause in children younger than 3 yrs? |
|
Definition
|
|
Term
4 Difference between normal and abnormal tympanic membrane, as seen in AOM? |
|
Definition
Abnormal tympanic membrane:
Decreased mobility of tympanic membrane |
|
|
Term
5 Differences between middle ear effusions and otitis media. |
|
Definition
|
|
Term
___ is common organism if recurrent otitis media. |
|
Definition
|
|
Term
___ are common organism if chronic otitis media. |
|
Definition
Staph Aureus, Pseudomonas, Proteus, Klebsiella, anaerobes, or biofilm |
|
|
Term
3 main pathogenesis of otitis media |
|
Definition
- - Abnormal anatomy: eustachian tube dysfunction
- - Host defenses: weel IgG, IgA, abnormal ciliary function, HIV+
- environmental factors: day care, URTI, bacterial colonization, bottle feeding
|
|
|
Term
|
Definition
|
|
Term
Difference between chronic and acute bronchitis.
· Which is only seen in adults?
· Which is self-limiting? |
|
Definition
Acute – occurs in all ages (self-limiting but can lead to asthma or COPD)
- Viruses are most common
- Some due to bacteria ex. Mycoplasma, chlamydia, strep pneumo, H. influenza
Chronic – adults only
- Nonspecific disease - Not specific group of pathogens causes bronchitis, both respiratory bugs are primary culprits
|
|
|
Term
Which type of bronchitis can lead to asthma or COPD. |
|
Definition
|
|
Term
4 differences between acute and chronic bronchitis. |
|
Definition
|
|
Term
Antibiotic treatment for bronchitis |
|
Definition
Ampicillin or Amoxicillin or Augmentin or Levofloxacin or Doxycycline or Bactrim |
|
|
Term
Antibiotic treatment for pharyngitis |
|
Definition
Pen V is 1st line, macrolides (Azithromycin) or Cephalosporins
|
|
|
Term
Antibiotic treatment for sinusitis |
|
Definition
2nd and 3rd gen cephalosporins, Levo or Moxifloxacin |
|
|
Term
Antibiotic treatment for sinusitis |
|
Definition
Bactrim, cephs, clarithromycin, clindamycin, and flouroquinolones (levo or cipro) + dexamthasone combos |
|
|
Term
What is difference between chronic and acute osteomyelitis? |
|
Definition
|
|
Term
Describe the 3 portal of entry in the pathophysiology of osteomyelitis. |
|
Definition
- Contiguous (most common – 47%): infection spreads from adjacent soft tissue infection or surgical/traumatic introduction of bacteria to bone.
- Hematogenous (most common in children): infection spreads via blood stream.
|
|
|
Term
Which route of osteomyelitis infection is common in children? Which is common in adults? |
|
Definition
Hematogenous = common in children
Contigous = common in adults >50 yrs
Vascular insufficiency = harder to manage & underlying disease usually present ex. diabetic foot ulcer |
|
|
Term
What are the site of hematogenous osteomyelitis involvement commonly seen in:
neonates, Adults, children, IV drug users, sickle cell patients? |
|
Definition
|
|
Term
Give the organisms seen in hematogenous osteomyelitis in neonates and their treatment. |
|
Definition
|
|
Term
Give the organisms seen in hematogenous osteomyelitis in children and their treatment. |
|
Definition
|
|
Term
Give the organisms seen in hematogenous osteomyelitis in adults and their treatment. |
|
Definition
|
|
Term
Give the organisms seen in hematogenous osteomyelitis in IV drug users and their treatment. |
|
Definition
MRSA, Pseudomonas, other GNB, S. epidermidis
|
|
|
Term
Give the organisms seen in hematogenous osteomyelitis in sickle cell and their treatment |
|
Definition
|
|
Term
Give the organisms seen in contiguous osteomyelitis in adults >50yrs and their treatment |
|
Definition
|
|
Term
When treating bone and joint infection, always cover ____.
|
|
Definition
|
|
Term
Consider ___ for treating streptococci and gram (-) caused osteomyelitis in children. |
|
Definition
|
|
Term
What is the duration of treatment for osteomyelitis? |
|
Definition
|
|
Term
What are the criteria for oral use for osteomyelitis? |
|
Definition
|
|
Term
Who are candidates for oral therapy for osteomyelitis? |
|
Definition
|
|
Term
What are 2 non-drug therapy for osteomyelitis? |
|
Definition
- Hyperbaric oxygen therapy
|
|
|
Term
What are the 2 types of infectious arthritis?
Which is monoarticular?
Which is the most common in children?
Which is more common in males?
Which is more common in females? |
|
Definition
Non-gonococcocal & Gonococcal
Monoarticular = non-gonococcal
Children & Males = non-gonococcal
Females = gonococcal
|
|
|
Term
What are the 3 sources of infection in the pathophys of infectious arthritis?
Which is most common?
Which is commonly from osteomyelitis that drains into joints? |
|
Definition
Hematogenous
Direct inoculation
Contiguous
Most common = hematogenous
from osteomyelitis that drains into joints = contiguous |
|
|
Term
What is the treatment for infants with infectious arthritis ? |
|
Definition
|
|
Term
What is the treatment for children with infectious arthritis without vaccination? |
|
Definition
|
|
Term
What is the treatment for people with STD and infectious arthritis? |
|
Definition
|
|
Term
What is the treatment for people with prothetic joints or post-surgery infectious arthritis? |
|
Definition
|
|
Term
What is the treatment for Adults unlikely to have STD but have infectious arthritis? |
|
Definition
|
|
Term
What is the treatment for IV drug user with infectious arthritis? |
|
Definition
|
|
Term
What is the duration of treatment for the gonococcal and non-gonococcal infectious arthritis? |
|
Definition
Gonococcal: 7-10 days of antibiotics |
|
|
Term
1. What findings are consistent with osteomyelitis?
2. What kind of osteomyelitis?
3. Give empiric treatment.
|
|
Definition
|
|
Term
Describe community-acquired pneumonia. |
|
Definition
|
|
Term
2. What kind of septic/infectious arthritis?
3. Empiric antibiotic therapy?
|
|
Definition
1. Elevated WBC & ESR, fever, acute monoarticular paint and swelling.
2. Non-gonococcal
3. allergic history: PCN allergy
|
|
|
Term
Name 5 organisms that cause community-acquired pneumonia |
|
Definition
|
|
Term
3 routes of CAP infection |
|
Definition
|
|
Term
Name 2 predisposing factors for community-acquired pneumonia. |
|
Definition
|
|
Term
Lab test for CA-pneumonia would show what? |
|
Definition
|
|
Term
|
Definition
a. previously healthy outpatient: macrolide or doxycycline
b. hospitalized patient in general medical ward: respiratory flouroquinolone or advanced macrolide + Beta lactam
c. hospitalized patient in ICU:
treat for MRSA with Vancomycin or Linezolid
for P. auriginosa with no BL allergy = Zosyn (if no BL allergy) + azithromycin or respiratoryFQ or 750 mg Levofloxacin QD or aminoglycoside + azithromycin, or an antipseudomonal FQ with aminoglycoside .
If allergic to Blactam= aztreonam in place of the beta lactam.
If no pseudomonas and no allergies = beta lactam + azithromycin or respiratory FQ
but if no pseudomonas and no allergy = beta lactama +azithromycin or respiratory flouroquinolones. |
|
|
Term
What is the treatment for a CAP out-patient that:
· Has suspected aspiration with infection?
· Was previously healthy?
· Comorbid infection?
· Recent use of antibiotics?
· Influenza with bacterial superinfection? |
|
Definition
|
|
Term
|
Definition
|
|
Term
what is the treatment for inpatient CA-pneumonia?
what if allergic to beta lactam? |
|
Definition
|
|
Term
Which of the followings is the most common pathogen to cause community-acquired pneumonia?
a. Staphylococcus aureus
b. Streptococcus pneumoniae
c. H. influenzae
d. Mycoplasma pneumoniae
|
|
Definition
|
|
Term
AB, 40 years old female, came to the ER with chief complain of high fever, chills, and productive cough. After physical exam and lab tests (including chest x-ray), AB was diagnosed with community-acquired pneumonia. AB was previously very healthy and didn’t have any medical problem (no known drug allergy). Which antibiotic therapy will be the most appropriate for AB?
a. Azithromycin
b. Moxifloxacin
c. Amoxicillin/clavulanate
d. Ciprofloxacin |
|
Definition
Previously healthy = Macrolide = (Azithro, Clarithro) |
|
|
Term
CD, 65 years old male, was just admitted to the medicine floor for CAP. CD was diagnosed as CHF 10 years ago and has been taking medications for CHF since then. CD reported he had allergy to penicillin, but didn’t remember what the reaction was. What antibiotic will be the most appropriate for the management of CD’s CAP?
a. Ceftriaxone IV + clarithromycin PO
b. Ampicillin/sulbactam IV
c. Doxycycline IV
d. Levofloxacin IV |
|
Definition
Answer = A
Medical ward/inpatient CAP = Respiratory FQ (Levo, Moxifloxacin & Gemifloxacin) or
Advanced Macrolide (Azithro & Clarithromycin) + Beta Lactam |
|
|
Term
EF, 70 years old female, was admitted to ICU for CAP. What antibiotic will be the most appropriate for EF’s CAP? What are alternatives if patient has severe beta lactam allergy? |
|
Definition
ICU therapy:
Pseudomonas + No allergy: BL + Respiratory FQ or Azithromycin
No pseudomonas + allergic: replace BL with Clindamycin
Pseudomonas + allergy: Antipseudomonal BL + Antipseudomonal FQ or Aminoglycoside + Azithro OR Aminoglycoside + Antipseudomonal FQ
Pseudomonas + allergy: replace antipseudomonal BL with Aztreonam |
|
|
Term
What are risk factors that would necessitate a P.auriginosa empiric therapy. What are risk factors for MRSA. |
|
Definition
Pseudomonas risk factors:
- Severe structural lung disease (i.e. bronchiectasis, cystic fibrosis)
- chronic steroid administration
- alcoholism
- frequent antibiotic therapy
MRSA risk factors:
· ICU admission
· Necrotizing or cavitary infiltrates
· Empyema
|
|
|
Term
what is the duration of therapy for CA-pneumonia? |
|
Definition
5 days - must be afebrile 48-72 hrs and should have no more than 1 CAP-associated sign of clinical instability
|
|
|
Term
Give the 3 factors to consider before IV-to-PO conversion for CAP. |
|
Definition
1. When patients are clinically stable for 24 hours
a. Temperature ≤ 37.8oC (100 oF) - no fever
b. Respiratory rate ≤ 24 breaths/min - no tachyapnea
c. Heart rate ≤ 100 beats/min - no tachycardia
2. Be able to take oral medications
3. Have adequate GI function to absorb the agent selected |
|
|
Term
what is the most common predisposing factor of HA-pneumonia? |
|
Definition
|
|
Term
This is the gold standard for diagnosis of HA-pneumonia |
|
Definition
|
|
Term
This method of HAP diagnosis is generally reserved for pediatric or immunosuppressed individuals when cause of pneumonia is unknown |
|
Definition
|
|
Term
This method of HAP diagnosis can give quantitative results but is invasive. |
|
Definition
Bronchoalveolar lavage - a type of fiberoptic bronchoscopy |
|
|
Term
Risk Factors for MDR Pathogens |
|
Definition
- Antibiotics within 90 days
- Current hospitalization ≥ 5 days (Late-onset pneumonia)
- High frequency of antibiotic resistance in the community or in the specific hospital unit
- Immunosuppressive disease and/or therapy
- Risk factors for HCAP
|
|
|
Term
6 Risk Factors for Health care acquired pneumonia |
|
Definition
- Hospital stay ≥ 2 days within 90 days
- Nursing home or extended care facility resident
- Home infusion therapy
- Chronic dialysis within 30 days
- Home wound care
- Family with MDR pathogen
|
|
|
Term
Which of the followings is NOT the risk factor for MDR pathogens?
a. Patient lives in a nursing home
b. Patient has been getting IV vancomycin therapy at home for osteomyelitis.
c. Patient was treated for UTI with ciprofloxacin last week.
d. Patient was admitted to the ICU for 5 days last year. |
|
Definition
A - has to be current hospitalization for 5 or more days |
|
|
Term
GIve pathogens with risk factors for MDR for HAP. |
|
Definition
Early onset:
o S. pneumoniae
o H. influenzae
o MSSA
o E. coli
o K. pneumoniae
o Proteus
Late Onset - always a risk factor
o ESBL producing K. pneumoniae
o P. aeruginosa
o Acinetobacter
o MRSA
o Legionella
|
|
|
Term
Agents for Patients with NO risk factors for multi-drug resistant pathogens or Early onset pneumonia
|
|
Definition
- Ampicillin/sulbactam 3 g q6h
- Ceftriaxone 1 g – 2 g q24h
- Ciprofloxacin (400 mg q12h), levofloxacin (750 mg q24h), or moxifloxacin (400 mg q24h)
|
|
|
Term
Give agents for Patients with risk factors for multi-drug resistant pathogens or Early onset pneumonia |
|
Definition
Anti-MRSA agent ( 600mg Linezolid Q12H or 15mg/kg Vancomycin Q12H)
+
Anti-pseudomonal BL (Zosyn or Ceftazidime or Cefepime or Imipenem/Cilastatin or Meropenem)
+
Antipseudomonal Aminoglycoside or Flouroquinolone |
|
|
Term
Which of the followings is NOT recommended for early onset pneumonia?
a. Ampicillin/Sulbactam 3 g IV q6h
b. Piperacillin/Tazobactam 4.5 g IV q6h
c. Levofloxacin 750 mg IV q24h
d. Ceftriaxone 1 g IV q8h |
|
Definition
|
|
Term
Which medications for HAP is dosed once daily? |
|
Definition
Levofloxacin (Levaquin) and Ceftriaxone (Rocephin) |
|
|
Term
what is the duration of treatment for HAP? |
|
Definition
7 days or 14 days (if fermentative Gram - is present after day 8) |
|
|
Term
The most common type of diarrhea is ___ |
|
Definition
|
|
Term
5 difference between watery and inflammatory diarrhea |
|
Definition
|
|
Term
differentiate between organisms that cause watery vs. inflammatory diarrhea. |
|
Definition
|
|
Term
What are ways that GI infection is diagnosed? |
|
Definition
|
|
Term
What is the most common cause of GI infections in the U.S? World? |
|
Definition
US: bacteria
Worldwide = virus |
|
|
Term
What is the cause of antibiotics-associated non-infectious diarrhea? |
|
Definition
|
|
Term
What is the difference between acute, persistent and chronic diarrhea? |
|
Definition
|
|
Term
What type of fluid replacement is recommended for GI infection? |
|
Definition
|
|
Term
What type of anti-motility is recommended for GI infection? When is it contraindicated? |
|
Definition
-Antimotility agents (diphenoxylate and loperamide)
-Symptom relief
-Contraindicated with presentation of high fever or bloody diarrhea --> prevents elimination of toxins
•Delays clearance of infectious microbes
•Increases toxin absorption
•Extended toxin-associated damage
|
|
|
Term
What type of absorbent is recommended for GI infection? |
|
Definition
|
|
Term
What type of anti-secretory agent is recommended for GI infection? What is the caveat? |
|
Definition
|
|
Term
When is antibiotics used for GI infections? |
|
Definition
Only used antibiotics for some confirmed infections due to Shigella, Campylobacter and Yersini |
|
|
Term
What antibiotics increase risk of c. diff. |
|
Definition
|
|
Term
Differentiate between toxin A and B of C. diff. which one is an enterotoxin? Which one is most potent? |
|
Definition
|
|
Term
How many cultures is needed for C. diff diagnosis? List them. which one is the preferred method? |
|
Definition
2 cultures:
ELISA for toxin A & B - preferred method but low sensitivity and specificity
&
Stool culture - sensitive but gives false positives |
|
|
Term
What is the treatment for C. diff infection:
· Initial or Mild-to-moderate?
· Initial but severe?
· Initial, severe and complicated?
· First relapse?
· Second relapse? |
|
Definition
|
|
Term
What is the duration of treatment for GI infections? |
|
Definition
|
|
Term
Which other type of C. diff treatment has only local GI effect? |
|
Definition
Rifaximin - can be used for multiple recurrence of C. diff |
|
|
Term
Which other type of C. diff treatment is an alternative agent in recurrent C.diff infection following metronidazole therapy? |
|
Definition
Nitazoxamide - non-inferior to oral vancomycin |
|
|
Term
Which other type of C. diff treatment is has no confirmed efficacy in controlled studies |
|
Definition
IV immunoglobin G (IVIG) - • Multiple relapses due to impaired antigenic response to toxins
|
|
|
Term
Which other type of C. diff treatment is as effective as PO vancomycin with lower recurrent rate? |
|
Definition
Fidaxomicin - macrocyclic ABX against G+ anaerobes like C. diff |
|
|
Term
Which other type of C. diff treatment is reserved for severe, refractory C.diff infection? |
|
Definition
Tigecyclive - a Glycylcycline (IV form only)
|
|
|
Term
Majority of Traveler’s diarrhea is caused by ____ |
|
Definition
|
|
Term
What agent is best for prevention of Traveler’s diarrhea? |
|
Definition
|
|
Term
Which antibiotic is used for Traveler’s diarrhea?
· Preferred ABX overall?
· Preferred if in Asia?
· Preferred if in Mexico or Jamaica?
· Is NEVER recommended? |
|
Definition
Preferred ABX overall? Fluoroquinolones
· Preferred if in Asia? Azithromycin
· Preferred if in Mexico or Jamaica? Rifamixin
· Is NEVER recommended? Bactrim and Dopxycycline |
|
|
Term
|
Definition
|
|
Term
When is salicylate bidmuth recommended for GI infection? |
|
Definition
For travler's diarrhea only |
|
|
Term
What is intra-abdominal infection (IAI)? |
|
Definition
Intra-abdominal infections: infections within the peritoneal cavity or retroperitoneal space. |
|
|
Term
2 common organisms found in stomach that cause IAI? |
|
Definition
|
|
Term
Differentiate between primary secondary, and tertiary peritonitis.
· Which is most common?
· Which is monomicrobial or polymicrobial? |
|
Definition
|
|
Term
Give the 2 types primary peritonitis. |
|
Definition
|
|
Term
Causative organisms in CAPD and SBP? |
|
Definition
|
|
Term
Which of the followings is the LEAST recommended to the patients with health care-associated Intra-abdominal infection?
a. piperacillin-tazobactam
b. doripenem
c. ciprofloxacin + metronidazole
d. tigecycline |
|
Definition
D - Tigecycline does not cover pseudomonas, only MRSA |
|
|
Term
Altered mental status is seen in what type of peritonitis, while cloudy effluent is observed in what type? |
|
Definition
Altered mental status - Spontaneous Bacterial Peritonitis (SBP)
loudy effluent - chronic ambulatory peritoneal dialysis
|
|
|
Term
Which type of peritonitis has more polymorphonuclear cells upon diagnosis |
|
Definition
• CAPD: >50% PMNs/mm3 is diagnostic
• SBP: ≥250 PMNs/mm3 is diagnostic
|
|
|
Term
What is the treatment for peritonitis? |
|
Definition
CAPD: Gram positive coverage (Cefazolin or Vancomycin) + Gram negative coverage (aminoglycoside, ceftazidime, cefepime, carbapenem, ciprofloxacin, levofloxacin)
SBP: a. Cefotaxime, ceftriaxone, fluoroquinolones
2° SBP prophylaxis (fluoroquinolone or Bactrim)
Secondary peritonitis: Antipseudomonal beta lactam or Moxifloxacin + Levofloxacin/Ciprofloxacin |
|
|
Term
______and ____are not recommended because of resistance among B fragilis. |
|
Definition
Clindamycin and Cefotetan |
|
|
Term
What are 6 causes of systemic fungal infection? |
|
Definition
-Common in immune-compromised patients
-Patients exposed to broad spectrum antibiotics
- Normal microorganisms are suppressed with fungal overgrowth
-Widespread use of indwelling medical devices
- Intravenous catheters, joint replacements
-Long-term maintenance of burn, trauma and diabetic patients
|
|
|
Term
Describes the 3 types of fungus. |
|
Definition
Yeast - Invasive and causes most infections - Unicellular and oval or spherical shape
Molds
- Free-living - Multicellular - Have filament
Dimorphic forms – exists as yeast or mold depending on conditions
- The yeast form infects humans - Free-living form exists as mold
|
|
|
Term
This fungi is typically not susceptible to most anti-fungals. |
|
Definition
|
|
Term
Describe lipid amphotericin B. |
|
Definition
|
|
Term
Name and describe the 3 types of lipid amphotericin B. |
|
Definition
- Amphotericin B colloidal dispersion (ABCD) - Amphotec- “discs” of lipids
- • Liposomal Amphotericin B formulation (L-AmB) - Ambisome-
- With artificial lipid vesicles
- • Amphotericin B lipid complex (ABLC) - Albecet
- • Has a phosphatidyl choline and phosphatidic acid in ribbon-like sheets
|
|
|
Term
|
Definition
|
|
Term
What is the MOA of amphotericin B?
|
|
Definition
|
|
Term
|
Definition
|
|
Term
- Does AmB have CNS/CSF penetration?
- Can it be used in pregnancy?
|
|
Definition
No CNS penetration, only with inflammation
Safe in pregnancy |
|
|
Term
What is the half-life of AmB?
|
|
Definition
3 days - 15 days of terminal elimination |
|
|
Term
What are main ADR of AmB? Does it require hepatic or renal adjustment.
|
|
Definition
Renally excreted, so Nephrotoxicy is major issue:
Also
- Hypokalemia
- Hypomagnesemia
- Hypotension and Stridor
- Anemia
- Thrombophlebitis
|
|
|
Term
What is the MOA of flucytocine?
|
|
Definition
|
|
Term
What is the spectrum of activity of flucytosine?
|
|
Definition
|
|
Term
What other antifungal is synergic of flucytosine?
|
|
Definition
|
|
Term
What is the route of admin for flucytocine?
What is the half-life of flucytocine?
Does flucytosine penetrate CNS?
|
|
Definition
Oral absorption
half-life = 3-6 hrs
Penetrates into CNS |
|
|
Term
Compare flucytocine and AmB.
|
|
Definition
AmB is IV/Intrathecal while Flucytocine is oral AmB targets cells wall/ion gradient(pores) and Flucytocine inhibits thmyidilic acid and disrupts RNA & protein synthesis Both are eliminated renally (adjust only for flucytocine) Only Flucytocine enters CNS AmB can be used against coccidio but not flucytocine
AmB has longer half-life (days) vs. 5-FC (hours) |
|
|
Term
What are the ADR of flucytocine.
|
|
Definition
-Bone marrow suppression -Reversible anemia, leukopenia and thrombocytopenia
-Hepatic dysfunction – rise in liver transaminase (even thogh excreted via urine)
- GI disturbances like nausea, vomiting and diarrhea and some cases of rash. |
|
|
Term
Give the imidazoles.
Give the 4 members of triazoles.
Which are 2nd gen of triazoles.
|
|
Definition
Imidazole (2 nitrogens in 5-mem ring): -ketoconazole, miconazole
Triazoles: -fluconazole, itraconazole, voriconazole, posaconazole
-Second Gen Triazoles: Voriconazole & Posaconazole |
|
|
Term
What is the spectrum of activity of azoles?
|
|
Definition
Candida (not krusei)
Cryptococcus - Fluconazole is 1st line
Aspergillus - Voriconazole is 1st line |
|
|
Term
What is a problem seen with azoles? Which azoles are the exception?
|
|
Definition
Azoles(except Posaconazole) inhibit gonadal and adrenal steroid synthesis pathway |
|
|
Term
What is the MOA of azoles?
|
|
Definition
MOA- azoles Inhibits synthesis of Ergosterol by stopping the conversion of lanosterol to ergosterol = components of fungal cell membrane are inhibited.
|
|
|
Term
Which azole shows up on CT scan?
Which azole is only oral?
|
|
Definition
Voriconazole - shows on CT scan
Posaconazole - oral only |
|
|
Term
Which azole is 1st line for Cryptococcus and Coccidio infection?
Which azole is used against zygomycetes?
Which azole is used against Aspergillus?
|
|
Definition
1st line for Crytococcus and Coccidio meningitis = Fluconazole
Zygomycetes = Posaconazole
Voriconazole = Aspergillus |
|
|
Term
Stomach acids have the least effect on this azole.
Which azole have the least CYP interaction
|
|
Definition
Posaconazole
Posaconazole |
|
|
Term
Which azoles are eliminated via hepatic metabolism? Which are renal?
|
|
Definition
Hepatic metabolism: Ketoconazole, Itraconazole, Voriconazole, Posaconazole
Renal: Fluconazole, Itraconazole, Voriconazole (excreted if with cyclodextrin, but not if CrCl is <50ml/min), |
|
|
Term
Parenteral formulations of ____have cyclodextrin, which is renally eliminated, so contraindicated if CrCl <50 ml/min.
|
|
Definition
|
|
Term
What is the CYP inhibited by:
· Itraconazole
· Fluconazole
· Voriconazole
· Posaconazole
|
|
Definition
· Itraconazole - CYP 3A4
· Fluconazole - 3A4 and 2C9
· Voriconazole - 3A4, 2C9 and 2C19
· Posaconazole - no cyp inhibited |
|
|
Term
What are some ADR seen with azoles?
|
|
Definition
-Hepatotoxicity –Rare, but can lead to hepatic failure and death; more common with ketoconazole (black box warning).
-GI distress with nausea, vomiting & diarrhea fairly common
-Skin rash and Alopecia seen fairly commonly
-QT prolongation: Cardiovascular actions seen: Inotropic effect noted for Itraconazole and it has black box warning for patients with heart failure; all azoles can cause prolongation of QT interval and possible development of “Torsades”
-Visual Disturbances & Hallucinations – sometimes seen with Voriconazole (20-30% patients; caution with night driving)
-Azoles should not be used in pregnancy; they cross the placenta to affect the fetus |
|
|
Term
What is the difference between rifamycins and azoles in terms of CYP.
|
|
Definition
Rifamycins (except Rifabutin) = CYP induction
Azoles (except Posaconazole) = CYP inhibition |
|
|
Term
What is the MOA of echinocandins?
|
|
Definition
•Echinocandins inhibit the synthesis of beta(1,3)-D-glucan a key component of the cell wall of many filamentous fungi |
|
|
Term
What is the spectrum of activity of echinocandins.
|
|
Definition
Candida, Invasive and refractory aspergillus
Never use echinocandin for cryptococcus |
|
|
Term
Why are echinocandins not used for Cryptococcus Neoformans
|
|
Definition
different enzyme catalyze cell wall formations and neoformans have a different linkage than other fungi |
|
|
Term
which echinocandins are used for invasive aspergillus?
Which is preferred in refractory aspergillus or if ptn is intolerant of other therapies?
Which is used for systemic candida?
Which echinocandin has CYP interaction?
What are major ADR of echinocandins.
What is the MOA of griseofulvin?
What is the MOA of Terbinafine? |
|
Definition
Invasive aspergillus - Caspofungin and Micafungin
Refractory (failed due to previous azole use) - Caspofungin
Systemic candida - Caspofungin and Anidulafungin
|
|
|
Term
What is the route of admin for echinocandins?
Describe PK of echinocandins.
Which echinocandin has CYP interaction?
|
|
Definition
Admin = IV only
Caspofungin & Micafungin = liver metabolism
Anidulafungin = spontaneous breakdown with no liver or renal help
CYP interaction = Micafungin |
|
|
Term
What are major ADR of echinocandins.
|
|
Definition
Generally safe
Hypokalemia - esp. Anidulafungin
Hypersensitivity - esp. Micafungin
rash and facial swelling due to rapid infusion
Altered renal and liver function trst
phlebitis, fever, N/V |
|
|
Term
What is the MOA of griseofulvin?
What is the MOA of Terbinafine? |
|
Definition
Griseofulvin - Acts on microtubule system to disrupt mitosis in certain fungal cells
Terbinafine - Reduces synthesis of ergosterol by inhibiting conversion of squalene to lanosterol by squaleneepoxidase
|
|
|
Term
What is a capsid?
What is a nucleocapsid?
What is a capsomere? |
|
Definition
• Viruses are obligate intracellular parasites
• Introduce nucleic acid into the host cell – can be single or double stranded DNA or RNA in a protein covering called capsid
• the capsid + nucleic acid = nucleocapsid
• Capsomere: repeating protein unit found on surfaces of viruses – extend into glycoprotein that determined host range.
• An outer phospholipid envelope is common, with glycoproteins extending from surface (e.g. influenza “A” virus has hemagglutinin and neuraminidase; “H” and “N”) |
|
|
Term
What determine virus host range?
___ promotes attachment and entry of virus? |
|
Definition
Host range & specificity = glycoproteins |
|
|
Term
Why is the development of new antiviral agents limited? |
|
Definition
|
|
Term
What are the 3 types of viruses. Give examples of each. |
|
Definition
DNA viruses: small pox, varicella (chicken pox), hepatitis B, Cytomegalovirus, human papilloma virus, herpes
RNA non-retrovirus: Hepatitis A & C, influenza, rabies, measles, mumps, polio
RNA retroviruses: HIV, Human T-cell Leukemia (HTLV) |
|
|
Term
Explain the 6 steps of replication of a virus. |
|
Definition
|
|
Term
What is the MOA of acyclic guanosine analogs? |
|
Definition
Viral thymidine kinase phosphorylates the valacyclovir (a prodrug) into an active triphosphate form (acyclovir) that mimics guanine nucleotide, but lacks the 3’ OH end. The viral DNA mistakenly uses this active form to build DNA and is unable to add another nucleotide to that 3’OH end, therefore ther DNA synthesis is terminated. |
|
|
Term
What is the spectrum of activity of acyclic guanosine analogs? |
|
Definition
•DNA viruses HSV-1 (oral) and HSV-2 (genital) herpes
•Varicella Zoster if started < 24 hr onset
•Cytomegalovirus prophylaxis (in immune deficient patients) |
|
|
Term
Which acyclic guanosine analogs are prodrugs? What are their active forms? |
|
Definition
Valacyclovir = Acyclovir
Famciclovir = Penciclovir
Valganciclovir = Ganciclovir
|
|
|
Term
Which acyclic guanosine analogs has the best oral absorption?
Which acyclic guanosine analogs has best activity against cytomegalovirus?
2 guanine analogs that have the worse myelosuppression are |
|
Definition
Famciclovir (and Valacyclovir) has superior GI absorption
Valganciclovir = best against cytomegalovirus
Valganciclovir and Ganciclovir |
|
|
Term
Give the 4 main ADR of guanosine analogs. |
|
Definition
Myelosuppression/Bone marrow suppression
Nephrotoxicity
Neurotoxicity |
|
|
Term
What is the preferred route of elimination for guanosine analogs? |
|
Definition
|
|
Term
What is the MOA of Cidofovir?
Compare and contrast Cidofovir MOA vs. Acyclovir |
|
Definition
•Cidofovirdiphosphate (3 Ps) inhibits viral DNA polymerase as the enzyme incorporates the drug into the nucleotide sequence of viral DNA in place of authentic CTP.
Cidofovir MOA vs. Acyclovir:
- Cidofovir is an analog of cytidine while acyclovir is a guanosine analog.
- Cidofovir has one phosphate, so it bypasses need for viral thymidine kinase (which adds the first phosphate)
|
|
|
Term
What is the spectrum of activity of Cidofovir?
Cidofovir is especially useful when virus enzyme ____ is inactive/deficient |
|
Definition
•DNA viruses ex. Herpes Simplex virus, Varicella-Zooster virus or Cytomegalovirus.
thymidine kinase |
|
|
Term
What is the preferred route of admin for Cidofovir compared to guanosine analogs? |
|
Definition
Cidofovir is IV
Guanosine analog is oral |
|
|
Term
what is the preferred route of excretion for cidofovir compared to acyclovir?
why does cidofovir have a long half-life (up to 87 hours)? |
|
Definition
Cidofovir = renal excretion
Acyclovir = renal excretion
Cidofovir forms metabolites (diphosphate/phosphocholine) which form intracellular reservoirs with long t1/2 (up to 87 hr); this permits infrequent or one time only dosing |
|
|
Term
Give the 2 main ADR of cidofovir. |
|
Definition
Nephrotoxicity (prevented with probenecid) and Myelosuppression (bone marrow suppression) just like guanosine analogs (but without the neurotoxicity of guanosine analogs) |
|
|
Term
What is the MOA of Foscarnet? |
|
Definition
Inhibits viral nucleic acid synthesis by noncompetitive inhibition of the pyrophosphate binding site on viral DNA polymerase, which means viral polymerase is unable to cleave pyrophosphate from dNTP as it elongates DNA by a unit of dNMP. |
|
|
Term
What is the spectrum of activity of Foscarnet? |
|
Definition
•Inhibitory against DNA viruses: ll Herpes Simplex Virus I & II, Varicella-zooster, Cytomegalovirus.
•Used against CMV and HSV/VZV that are resistant to acyclovir |
|
|
Term
What makes Foscarnet special compared to cidofovir and acyclovir? |
|
Definition
ADR: all 3 cause nephrotoxicity, but Foscarnet's nephrotoxicity can be prevented with prior saline hydration, and cidofovir with probenecid to prevent reservoir.
Admin: bith foscarnet and cidofovir are IV, while acyclovir is oral.
Note: Foscarnet causes hypocalcemia but not myelosuppression, while both acyclovir and cidofovir causes bone marrow suppression
Both Foscarnet and acyclovir causes neurotoxicity but not cidofovir |
|
|
Term
What is the preferred route of admin for Foscarnet?
What is the preferred route of elimination for Foscarnet?
Give the 3 main ADR of Foscarnet. |
|
Definition
Foscarnet is IV
Renal excretion for Foscarnet
ADR:
- Hypocalcemia
- Nephrotoxicity (prevent with saline hydration prior)
- Neurotoxicity
|
|
|
Term
How can you prevent nephrotoxicity with foscarnet use? |
|
Definition
|
|
Term
What is the MOA of Fomivirsen? |
|
Definition
•Antisense, sense and dsRNA therapy may mimic regulatory RNA molecules (siRNAs and miRNAs) and down-regulate viral gene expression to inhibit viral DNA replication (“Gene Silencing”) |
|
|
Term
What is the spectrum of activity of Fomivirsen?
What makes Fomivirsen special compared to Foscarnet? |
|
Definition
•Was used for CMV retinitis (intravitreal injection) if patient intolerant or nonresponsive to other agents.
Formivirsen was the 1st antisense therapy and it is no longer marketed due to lack of demand |
|
|
Term
What is the MOA of Amantadine & Rimantadine?
What is the spectrum of activity of Amantadine & Rimantadine?
|
|
Definition
•Inhibition of viral “uncoating” and assembly of surface glycoproteins like hemagglutinin on the nascent virion
Spectrum: Influenza A |
|
|
Term
How is influenza A classified?
|
|
Definition
Classified by glycoproteins: Hemagluttin and Neuraminidase |
|
|
Term
What is the MOA of Oseltamivir and Zanamivir?
Give their brand names and spectrum of activity.
|
|
Definition
•Oseltamivir and Zanamivirinhibit neuraminidase and block the release of progeny virus from infected host cells; viral particles aggregate on the cell surface and the infection is not spread.
Oseltamivir = Tamiflu
Zanamivir = Relenza
Spectrum: Influenza
|
|
|
Term
Compare and contrast the MOA of Amantadine & Rimantadine vs. Oseltamivir and Zanamivir.
Compare their spectrum of activity and route of admininistration and excretion. |
|
Definition
Amantadine/Rimantadine MOA = prevents viral uncoating & assembly
Oseltamivir/Zanamivir =inhibits sialic acid = prevents viral progeny spread
Spectrum of activity:
Amantadine/Rimantadine = Influenza A only
Oseltamivir/Zanamivir = Influenza A and B
Route of admin:
Amantadine/Rimantadine = both are oral
Oseltamivir = oral
Zanamivir = intranasal (do not use if bronchospasm)
Excretion:
Amantadine (no longer in use) = renal excretion
Rimantadine (still used) = 75% liver and 25% renal
Oseltamivir/Zanamivir = both renal
|
|
|
Term
|
Definition
Oseltamivir (Tamiflu®)and Zanamivir (Relenza®) |
|
|
Term
List the the 5 antiviral agents used to treat hepatitis B (DNA virus) & C RNA virus) |
|
Definition
Adefovir
Ribavirin
Lamivudine and Telbivudine
Recombinant and Natural Interferons |
|
|
Term
What is the MOA of adefovir?
Give its spectrum of activity.
what is the preferred route of admin and elimination?
Give one major ADR. |
|
Definition
•MOA: mimic adenosine nucleotides by entering host cells as prodrug where the phosphonate side chain is broken; product is phosphorylated by kinases to Adefovirdiphosphate (3 phosphates!) •It is “acyclic” however, so it serves as a high-affinity competitive inhibitor of viral DNA polymerase.
Spectrum Hepatitis B
Admin = oral
Elimination = Renal (adjust if CrCl <50 ml/min)
Major ADR: Nephrotoxicity |
|
|
Term
What is the MOA of Recombinant and Natural Interferons?
Give its spectrum of activity.
what is the preferred route of admin and elimination?
Give major ADRs. |
|
Definition
MOA: proteins that inhibition of transcription, translation, processing of key viral proteins and maturation and release of new viral particles. •Most studied MOA is activation of JAK-STAT pathway; sets off a chain of host factors that up-regulate genes for 24+ proteins
Spectrum = Hepatitis B & C & Kaposi Sarcoma in HIV
Admin = IV or IM over 6 hrs
Elimination = Renal, liver and tissue uptake
Major ADR: Myelosuppression, neurotoxicity, CYP inhibition, and autoimmune disorders |
|
|
Term
What is the MOA of Lamivudine and Telbivudine?
Give its spectrum of activity.
what is the preferred route of admin and elimination?
Give major ADRs. |
|
Definition
MOA: Nucleoside analogs of the pyrimidines cytosine (Lamivudine) or thymine (Telbivudine) that are phosphorylated by kinases to triphosphates (active forms) and are used by Hepatitis B DNA polymerase (also HIV reverse transcriptase) for authentic C or T nucleotides causing inhibition of DNA synthesis. Neither permits the proper 5’ to 3’ link. •Lamivudine has a sulfur at the 3’ end, while Telbivudine is an L-stereoisomer of thymidine rather than the required D-form.
Spectrum = Hepatitis B
Admin = both are oral
ADR: liver enlargement and hepatic transaminase in some patients |
|
|
Term
What is the MOA of Ribavirin (a.k.a. Tribavirin)?
Give its spectrum of activity.
what is the preferred route of admin and elimination?
Give major ADRs. |
|
Definition
MOA: •Primary MOA: inhibition of the enzyme Inosine-5’-phosphate dehydrogenase, which decreases synthesis of GTP and thus nucleic acids in general. è GTP prevents degradation of nucleic acid.
•Secondary MOA: inhibition of post-transcriptional processing of viral mRNA (5’ capping, which is a GTP dependent process)
Spectrum = Used with interferon-α for Hepatitis C and as aerosol for Respiratory Syncytial Virus (RSV)
Admin = oral or IV
Elimination = Hepatic metabolism and renal elimination
ADR: dose-related myelosuppression |
|
|
Term
Describe the 3 major genes of HIV virus. |
|
Definition
• Gag – encodes proteins to cause release of the major structural proteins
• Pol – encodes RNA-dependent DNA polymerase (reverse transcriptase), protease and viral integrase
• Env – encodes transmembrane envelope protein responsible for cell binding and entry (gp120 & gp41). |
|
|
Term
Describe the enzyme reverse transcriptase. |
|
Definition
• RNA dependent DNA polymerase viral enzyme that synthesizes duplex strands of DNA from a single strand of viral RNA (the reverse of transcription) in three steps.
• Has no proofreading function, so mutations are common at rate of about 3 errors/cycle (humans have a 3’ to 5’ exonuclease that excises errors, so they can be corrected). |
|
|
Term
Describe the 3 steps of retrovirus replication. |
|
Definition
1.Synthesis of a complementary strand of DNA that matches the imported viral RNA.
2.Original RNA strand is degraded.
3.Make a second copy of the DNA using the first DNA copy to form a double-stranded DNA, which is then inserted into host cell to be quiescent (latent).
|
|
|
Term
Describe the 6 major phases of HIV life cycle. |
|
Definition
- Attachment to a host immune cell via gp120 - binds to CD4+ T cell and to either CXCR4 or CCR5.
- Cellular Uptake (Fusion or Entry) - A function of gp41
- Uncoating
- Replication, Transcription, Integration & Translation - original RNA strand degraded by reverse transcriptase RNase H.
- Assembly
- Release of New Virus Particles - post-translational modification of gag and pol by viral protease.
|
|
|
Term
What are the functions of glycoproteins of HIV? |
|
Definition
Attachment (gp120) and fusion (gp41) |
|
|
Term
|
Definition
gp120 selectivity for either CXCR4 or CCR5 co-receptors on immune cells.
Can be dual tropism.
–The CXCR4 co-receptor is more common on T-Helper cells, so virus tropic for CXCR4 is termed X4-tropic or T-tropic; the initial attack is on CD4+T-Helper cells. If the HIV strain prefers the co-receptor CCR5 (more common on macrophages), then the term R-5 tropic or M-tropic is used and the initial attachment and entry is on CD4+ Macrophages
|
|
|
Term
Describe the course of HIV infection starting from the initial infection to the critical threshold and setpoint. |
|
Definition
Initial infection spreads virus to CD4 Tcells, macrophages and lymphoid organs etc--> acute viremia (mono-or flu-like illness with rash, N/V/D) --> immune compensation(decrease viral load with decreased CD4+ and increased CD8) --> Set point (95% have antibodies within 6 mo A “set-point” of viral load (RNA) correlates with AIDS morbidity and mortality) --> clinical latency --> progression --> critical threshold (CD4 + T cell = 200/mm3) |
|
|
Term
Describe the 4 lab tests for HIV detection.
which is for screening and which is for confirmation? |
|
Definition
ELISA = sensitive = for screening
Western blot = specific = for confirmation
Viral isolation and culture
PCR |
|
|
Term
HIV vaccine development have been limited by what is called _____. |
|
Definition
Moving target = mutation rate is high |
|
|
Term
2 main goals of HIV therapy are |
|
Definition
- Suppress viral load to <50 RNA copies/mL
- Preserve immune function
|
|
|
Term
WHat is Immune Resconstitution Syndrome?
|
|
Definition
•occur following initiation of ART, as the immune system regains functionality against opportunistic pathogens; signs are non-specific (e.g. fever & inflammation) and dependent on the pathogen – the clinician must differentiate IRS from progression of HIV-induced disease |
|
|
Term
Describe the metabolic syndrome suffered by HIV patients. |
|
Definition
•Metabolic Syndrome: insulin resistance, fat redistribution, hyperlipidemia (HIV lipodystrophy syndrome) and myocardial infarction; specific drug classes have hallmark toxicities as well. One of the great ironies of HIV/AIDS is that some patients now die not from AIDS, but from MI and stroke due to adverse drug reactions brought on by ART. |
|
|
Term
Name the 6 classes of anti-HIV drugs. |
|
Definition
•Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
•Competitive inhibitors of viral RT (initially competitive but after installation in viral DNA, function as irreversible terminators)
•Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)*
•Non-competitive inhibitors of viral RT
•Protease Inhibitors (PI)
•Inhibit the post-translational, final activation step of viral polyproteins as the nascent viral particles are released
•Fusion Inhibitors (FI; a.k.a. “Entry Inhibitors”)*
•Block attachment and/or entry of the viral particle into cells
•CCR5 Co-Receptor Antagonists (CCR5I)
•Block attachment of certain strains of HIV to the R5 co-receptor and thus prevent entry and infection of immune cells
•HIV Integrase Strand Transfer Inhibitors (ISTI)*
•Inhibit the transfer and integration of the viral DNA into host cell DNA in the genome of the infected cell |
|
|
Term
|
Definition
competitive inhibition viral reverse transcriptase.
NRTI --> phosphorylated in cells into triphosphates which compete with native molecules for incorporation into viral DNA via viral reverse transcriptase. Incorporated analogs block DNA chain elongation due to absence of 3-hydroxyl group on the ribose-like moiety; thus viral DNA synthesis from the RNA template is inhibited. The absence of a 3-OH group prevents continuation of the 5’ to 3’ to 5’ to 3’ etc link through viral DNA. |
|
|
Term
Give an examples of Nucleotide antimetabolites. |
|
Definition
Tenofovir disproxil - mimics Adenosine |
|
|
Term
Give the 2 subclasses of NRTI agents. Give their examples and which analog their mimic. |
|
Definition
Antimetabolites - Nucleosides and Nucleotides
Cytidine Nucleoside analogs = Zalcitabine, Emtricitabine, Lamivudine
Thymidine Nucleoside analogs = Zidovudine & Stavudine
Adenosine nucleoside analog = Abacavir
Adenosine nucleotide analog = Tenofovir disproxil
Didanosine = I
|
|
|
Term
What is the preferred route of admin for NRTI?
which NRTI has the lowest overall bioavailability?
which has the longest half-life?
What is the preferred route of excretion? |
|
Definition
Oral, except Didanosine
Tenoforvir = lowest overall bioavailability
longest t.5 = Tenofovir
Route of excretion = renally except for Zidovudine, Didanosine and Abacavir |
|
|
Term
This NRTI is the only member affect by acid and needs to be taken with antacid to improve overall bioavailability. |
|
Definition
|
|
Term
give the major ADR of NRTI |
|
Definition
•GI Irritation – Nausea, vomiting & diarrhea
•CNS – headache, insomnia, dizziness, fatigue, and peripheral neuropathy
•Musculoskeletal and Dermatological – myalgia, arthralgia, rash/urticaria, fever
•Bone marrow suppression – expect to see anemia, granulocytopenia and thrombocytopenia (watch platelet count).
•Rare lactic acidosis and liver damage – zidovudine, stavudine (likely the worst offender of the group), didanosine, zalcitabine (DNA pol-γ effect; causes blockade of lactate transport into liver mitochondria, causing lactic acid to accumulate in cytoplasm and spill into blood).
•Note: Generally, NRTI have lower risk of drug interactions with this class vs other HIV agents, but use care with other drugs having similar adverse effects as shown above
|
|
|
Term
What is the MOA of NNRTI? |
|
Definition
non-competitive inhibitors
MOA: Noncompetitive inhibitors of HIV-1 only. NNRTI bind to a hydrophobic pocket on the viral enzyme reverse transcriptase; a site “distant” from the active site. They induce a conformational change in enzyme that reduces catalytic activity. |
|
|
Term
Give 3 examples of NNRTI. |
|
Definition
•Examples of NNRTI:
•Efavirenz
•Etravirine
•Rilpivirine (RPV; Edurant® and in 3-drug combo as Complera®) |
|
|
Term
Contrast MOA of NRTI and NNRTI |
|
Definition
NRTI = competitive inhibition of reverse transcriptase by mimicing an analog that lacks a 3-OH end.
NNRTI = non-competitive inhibitor of reverse transcriptase by binding near active site and causing a conformational change that reduces catalytic activity of the enzyme. |
|
|
Term
This NNRTI should be avoided during 1st trimester of pregnancy. |
|
Definition
|
|
Term
This NNRTI has psychological effect and is often abused due to this. |
|
Definition
|
|
Term
This NNRTI has the highest half-life and is dosed once a day. |
|
Definition
|
|
Term
What is the preferred route of admin for NNRTI?
What is the route of excretion for NNRTI? |
|
Definition
Route = oral
Excretion = Hepatic |
|
|
Term
Which CYP plays a role in NNRTI metabolism? |
|
Definition
|
|
Term
What are the 6 major ADR for NRTI? |
|
Definition
•Dermatological – rash, urticaria
•GI – Nausea, vomiting and diarrhea
•CNS – headache, fatigue, dizziness, nightmares, psychosis
•Efavirenz abusedàvia grinding tablets to powder & smoking; CNS depressant effects seen with dysphoria
•Rilpivirineàhave less severe ADRs compared to Efavirenz , but similar overall spectrum & type of adverse effects seen.
•Bone marrow suppression
•Metabolic – lipodystrophy, pancreatitis, liver toxicity
CYP involvement |
|
|
Term
These anti-retroviral agent is both an inhibitor and inducers of CYP 3A4.
what is the net effect? |
|
Definition
NNRTI = Efavirenz & Nevirapine
Net effect is induction. |
|
|
Term
What is the MOA of Protease Inhibitors? |
|
Definition
Inhibits cleavage of gag and pol proteins by viral proteases which mediate Post-Translational Modification reactions. They cleave/activate proteins; are required for maturation of virions into fully infectious virus. |
|
|
Term
___ is a Protease Inhibitors used as example of a rational drug design? |
|
Definition
|
|
Term
This Protease Inhibitors given with Ritonavir during pregnancy. |
|
Definition
|
|
Term
This Protease Inhibitors has the least endocrine ADR and less lipodystrophy. |
|
Definition
|
|
Term
What is the preferred route of admin for Protease Inhibitors?
What is the route of excretion for Protease Inhibitors? |
|
Definition
route of admin = bioavailability varies (oral and IV)
Excretion = Hepatic by 3A4 |
|
|
Term
Explain the 2 principles behind pharmocobooster of ritonavir. |
|
Definition
•First: Ritonavir is a strong inhibitor of CYP3A4, so in fairly low doses it will inhibit metabolism of other HIV drugs, both by preventing their metabolism in the GI tract and also by inhibition of first-pass metabolism as they circulate to liver
•Second: Ritonavir has affinity for the P-gp efflux pump system, and we can take advantage of this property also – the drug acts as a competitive inhibitor of that system and thus permits accumulation of a second HIV medication (higher blood levels, CNS entry, etc) |
|
|
Term
What are the 6 major ADR for Protease Inhibitors? |
|
Definition
•GI – Nausea, Vomiting and Diarrhea with pain
•Dermatological – rash, urticaria
•CNS – headache, fatigue, dizziness, sleep and taste disturbances, fever
•Musculoskeletal – myalgia, arthralgia
•Bone marrow suppression
•Metaboliceffects – lipodystrophy, pancreatitis, liver tox
•CYP Drug interactions – Many opportunities since CYP 3A4 is inhibited to various degrees by all of the PI agents |
|
|
Term
What is the MOA of Fusion Inhibitors?
Give examples of FI.
Give spectrum |
|
Definition
•MOA: binds to hydrophobic groove in protein gp41 and prevents membrane fusion.
Ex. Enfurvirtide
Spectrum: HIV-1
|
|
|
Term
which ART agents target only HIV-1? |
|
Definition
NNRTI and Fusion inhibitors |
|
|
Term
What is the preferred route of admin for Fusion Inhibitors?
What is the route of excretion for Fusion Inhibitors? |
|
Definition
route of admin = Parenteral (subQ or powder)
Excretion = distributes to extracellular fluid |
|
|
Term
What are the 3 major ADR for Protease Inhibitors? |
|
Definition
•Injection sites show some reactions –pain, erythema, urticaria by nearly all patients in first week of use
•Respiratory infections are increased in some patients.
•Hypersensitivity reactions are rare. |
|
|
Term
What is the MOA of CCR5 Co-Receptor Antagonists?
Give examples of CCR5 Co-Receptor Antagonists.
What is the brand name for CCR5 Co-Receptor Antagonists. |
|
Definition
•MOA: blocks CCR5; will be effective only if the specific HIV strain requires CCR5 (tropisms).
Ex. Maraviroc = Selventry |
|
|
Term
Test needed before Maraviroc use. |
|
Definition
Tropism test for CCR5 with Trofile assay |
|
|
Term
What is the preferred route of admin for CCR5 Co-Receptor Antagonists? |
|
Definition
|
|
Term
|
Definition
- CYP3A4 interaction (as substrate)
- Hepatoxicity - black box warning
- Myocardial ischemia and postural hypotension
|
|
|
Term
What is the route of excretion for CCR5 Co-Receptor Antagonists? |
|
Definition
Liver - substrate for CYP metabolism |
|
|
Term
What is the MOA of Integrase Strand Transfer Inhibitors (ISTI)?
Give examples of Integrase Strand Transfer Inhibitors (ISTI) and their brand names. |
|
Definition
•MOA: ISTI agents inhibit HIV-1 integrase– the enzyme that mediates the insertion or integration of the HIV DNA into the host cell genome; formation of “provirus” is inhibited
•Inhibits provirus, which directs production of new virus particles, so blocking integration prevents viral propagation
ex. Raltegravir (Isentress) and Elvitegravir |
|
|
Term
|
Definition
•A CYP3A4 inhibitor that is used as a booster for a new Integrase strand Inhibitor called Elvitegravir.
|
|
|
Term
What is the preferred route of admin for Integrase Strand Transfer Inhibitors (ISTI)?
What is the route of excretion for Integrase Strand Transfer Inhibitors (ISTI)? |
|
Definition
Admin = oral
Excretion = Feces and urine |
|
|
Term
What are the 5 major ADR for CCR5 Co-Receptor Antagonists? |
|
Definition
•General – Nausea, vomiting and diarrhea
•Some patients report increased incidence of headache
•More serious issues:
•Hypersensitivity
•DecreasedBone marrow
•MI
•Renal pathology |
|
|
Term
Describe the 3 types of infection caused by mycobacteria. |
|
Definition
–Local or Primary (granuloma formation; 10% progress on)
–Disseminated or Secondary (“Reactivation” disease; spread in bloodstream)
–Extrapulmonary or “Miliary” (involvement of other tissues in the body) |
|
|
Term
Name the 3 slow-growing mycobacterium. Which one is identified as a fast-grower. |
|
Definition
•Slow growers:
•Mycobacterium tuberculosis - causes tuberculosis
•Mycobacterium avium- seen in HIV patients
•Mycobacterium leprae - causes leprosy
•Fast grower:
•Mycobacterium fortuitum– opportunistic infections, especially lung, skin, soft tissues (trauma, indwelling medical devices, wound dressings) |
|
|
Term
Give 3 characteristics of a mycobacteria. |
|
Definition
•Thick, waxy cell wall - allows them to withstand harsh conditions
•Innermost layer = Peptidoglycan layer
•Outer layers =Composed of mycolic acid, arabinogalactan, and lipoarabinomannan (mannose sugars)
•Staining - Difficult to stain. Cell wall causes them to retain dye when decolorized with acid-ethanol and thus are called "acid fast.“ ID by staining important clinically, since growth often very slow and treatment delayed.
•Mycolic acids: Comprises approximately 60% of cell wall and makes such cells relatively impermeable. |
|
|
Term
Name 4 1st lines agents used for mycobacterium infection. |
|
Definition
1. Isoniazid
2. Rifampin
3. Ethambutol
4. Pyrazinamide |
|
|
Term
Name 5 2nd line agents for mycobacterium infection. |
|
Definition
•Streptomycin (and other AGs; parenteral)
•P-Aminosalicyclic Acid (PAS) - second line oral agent
•Cycloserine - second line oral agent
•Ethionamide - second line oral agent
•Miscellaneous other agents – Quinolones, Linezolid, Azithromycin, Interferon-γ |
|
|
Term
What is the MOA of Isoniazid? |
|
Definition
•MOA: as a prodrug, INH gets converted by mycobacterial catalase-peroxidase (KatG) to active metabolite, which is forms an adduct with NAD; the INH-NAD adduct inhibits the biosynthesis of mycolic acids and blocks formation of cell wall by blocking the enzyme enoyl ACP reductase, a component of fatty acid synthase complex. |
|
|
Term
What is an alternate used for Isoniazid? |
|
Definition
Treatment or prophylaxis for mycobacterium tuberculosis |
|
|
Term
What is the spectrum of activity of Isoniazid? |
|
Definition
•Active against Mycobacterium tuberculosis
•Bacteriostatic against quiescent mycobacteria, but bactericidal if cells are actively dividing
•Readily penetrates host cells, so effective against intracellular and extracellular bacteria |
|
|
Term
what is the preferred route of admin for isoniazid?
What is the metabolism/excretion route of Isoniazid? |
|
Definition
Isoniazid = oral or IV
Excretion = hepatic via N-acetyltransferase type 2 (NAT-2) |
|
|
Term
N-acetyltransferase type 2 is an enzyme that play a roles in metabolism of ____ |
|
Definition
hepatic metabolism of Isoniazid into active metabolite against mycobacterium tuberculosis |
|
|
Term
Give some ADR of Isoniazid. |
|
Definition
•Vitamin B6 antagonism:INH is an antagonist of Vitamin B6 (pyridoxine), so typically the vitamin is supplemented along with INH therapy; B6 does NOT interfere with therapeutic actions but can help reduce ADR.
•Peripheral neuritis – inflammation in peripheral nervous system nerves. More common in slow acetylators and persons with anemia or poor nutrition. B6 cuts incidence to <0.2%
•CNS – dizziness, memory impairment, slurred speech and lethargy. In high or overdose situations, can see seizures!
•Dermatologicaleffects
•Anemia in some patients.
•Hepatotoxicity - Potentially fatal, thought to be related to toxic metabolites of acetylhydrazine formed from CYP 2E1.
•Incidence rises in middle age and in those patients with significant alcohol intake.
•Patients taking isoniazid should be monitored for symptoms of hepatitis
•Overall incidence of adverse reactions – about 5.4% (in patients with concurrent pyridoxine therapy)
•CYP inhibition:
•Inhibits CYP 3A4, 2C19, and 2E1
•Example - Inhibits metabolic clearance of phenytoin (CYP 2C9 & 2C19) and leads to toxicity in ~25% of patients given both drugs.
•Other drugs of concern – monitor closely:
•Carbamazepine
•Warfarin
•Primidone |
|
|
Term
This agents are known to inhibit pyridoxine. |
|
Definition
vitamin B6 inhibition = Isoniazid & Ethionamide (2nd line agent that is isoniazid analog but with a thiol group) |
|
|
Term
Isoniazid inhibits these 3 types of CYP |
|
Definition
|
|
Term
What is the MOA of Rifamycins? |
|
Definition
•MOA: Rifampin blocks transcription (DNA to mRNA) by interacting with the β-subunit of mycobacterial DNA-dependent RNA polymerase, whichsuppresses initiation of the new mRNA chain. |
|
|
Term
What is the spectrum of activity of Rifamycins? |
|
Definition
–Broad spectrum and inhibits growth of many gram-positive and gram-negative bacteria
–Bactericidal activity against Mycobacterium tuberculosis |
|
|
Term
2 classes of agents that affect mitochondrial DNA |
|
Definition
Rifamycins and NRTI (esp. Zalcitabine, Zidovudine, Stavudine & Didanosine) |
|
|
Term
Give the preferred method of administration for Rifamycins.
Route of excretion? |
|
Definition
Oral (Rifampin is best if parenteral)
Excretion = hepatic via enterohepatic recycling |
|
|
Term
Give some ADR of Rifamycins. |
|
Definition
- CYP induction – 3A4, 2C9, 2C19, 1A2
- Hepatoxicity
- color change in contact lense and urine
|
|
|
Term
What is the MOA of Ethambutol? |
|
Definition
•Blocks cell wall synthesis by inhibiting arabinosyltransferase.
•Arabinose is a 5-carbon sugar that is incorporated into the mycobacterium cell wall. |
|
|
Term
What is the MOA of Ethambutol?
|
|
Definition
|
|
Term
What is the spectrum of activity of Ethambutol?
Give the preferred method of administration for Ethambutol.
What is the metabolism/excretion route of Ethambutol? |
|
Definition
Spectrum = bacteriostatic against mycobacterium tuberculosis
Administration = oral
Excretion = Renal |
|
|
Term
Give some ADR of Ethambutol. |
|
Definition
•Causes gout precipitation – reduces urate excretion
•Worsened if given together with Pyrazinamide.
•Eye toxicity: optic neuritis and diminished visual acuity – periodic eye exam necessary.
•Rash (0.5%)
•Fever (0.3%) |
|
|
Term
What is the MOA of Pyrazinamide? |
|
Definition
a prodrug that must be hydrolyzed to pyrazinoic acid for activity. It blocks mycobacterial fatty acyl synthase involved in mycolic acid synthesis (cell wall component). |
|
|
Term
Give difference between MOA of ethambutol and pyrazinamide |
|
Definition
Ethambutol inhibit Arabinosyl transferase used for mycobacterium cell wall
Pyrazinamide inhibits fatty acyl synthase of used to make mycolic acid for cell wall. Works best in acidic environment. |
|
|
Term
Give some ADR of Pyrazinamide. |
|
Definition
Hepatoxicity and gout
–Other adverse reactions - arthralgias, nausea, vomiting, fever, malaise, and dysuria. |
|
|
Term
Avoid aluminum antacid when taking this anti-tuberculosis agent. |
|
Definition
|
|
Term
What is the MOA of Streptomycin?
What is the spectrum of activity of Streptomycin? |
|
Definition
MOA: Binds to 30S ribosome and inhibits protein synthesis (decreases initiation, incorporation errors & misreads, premature termination).
•1st oral therapeutic drug for tuberculosis
•Bacteriocidal against Mycobacterium tuberculosis.
|
|
|
Term
Give the preferred method of administration for Streptomycin.
What is the metabolism/excretion route of Streptomycin? |
|
Definition
Route = Parenteral
Excretion = Renal |
|
|
Term
Give some ADR of Streptomycin. |
|
Definition
•same as other aminoglycoside
Ototoxicity (4%)
•Nephrotoxicity tends to be less than other AGs since doses are lower and this agent does not concentrate as much in renal cells
•Rash (2%)
•Fever (1.4%) |
|
|
Term
What is the MOA of Para-Aminosalicylic Acid (PAS)?
what is route of admin and ecretion? |
|
Definition
Competitive inhibitor of PABA as used by the enzyme Dihydropteroate synthase for folate synthesis
2nd line agent against mycobacterium tuberculosis
Admin = IV
excretion = renal |
|
|
Term
What is the MOA of Cycloserine?
What is the spectrum of activity of Cycloserine?
Give the preferred method of administration for Cycloserine).
What is the metabolism/excretion route of Cycloserine? |
|
Definition
•MOA: Competes for D-alanine in bacterial cell wall synthesis reactions
Admin = Oral
excretion = renal |
|
|
Term
Give some ADR of Cycloserine. |
|
Definition
•CNS side effects – headache, tremor, confusion, irritability, psychosis, seizures |
|
|
Term
What is the MOA of Ethionamide?
What is the spectrum of activity of Ethionamide?
Give the preferred method of administration for Ethionamide.
What is the metabolism/excretion route of Ethionamide? |
|
Definition
•Same MOA as Isoniazid: blockade of enzyme Enoyl ACP reductase to inhibit production of mycolic acid for cell wall
•Structural analog of isoniazid with sulfur - "thio" group.
route = oral
excretion = hepatic
|
|
|
Term
Give the 3 flouroquinolones that are used as alternative agents for tuberculosis. |
|
Definition
CLM- Cipro, Levo and Moxifloxacin |
|
|
Term
Give the 3 respiratory fluoroquinolones. |
|
Definition
GLM - Gemifloxacin, Levofloxacin and Moxifloxacin |
|
|
Term
Give the antipseudomonal fluoroquinolones. |
|
Definition
CLO - Ciprofloxacin, Levofloxacin and Ofloxacin |
|
|
Term
4 of these is not a used for mycobacterium tuberculosis treatment.
- Quinolones
- Azithromycin
- Clarithromycin
- Linezolid
- Aztreonam
- Interferon gamma
- Bactrim
- Vancomycin
|
|
Definition
- Clarithromycin
- Aztreonam
- Bactrim
- Vancomycin
|
|
|
Term
Which 4 antimycobacterial agents have CNS penetration?
|
|
Definition
Isoniazid
Rifamycins
Cycloserine
Ethionamide |
|
|
Term
Which 2 antimycobacterial agents have are prodrugs? |
|
Definition
|
|
Term
Explain the pathophysiology of malaria. |
|
Definition
•Malarial parasites utilize heme from hemoglobin as a source of iron and nutrition; they cannabilize the huge amount of Hb found in erythrocytes. |
|
|
Term
This type of genus of malaria-causing specie causes the most mortality. |
|
Definition
|
|
Term
Drug-resistant strains of ___and ____ are also known and are increasing in number. |
|
Definition
P. falciparumand P. vivax |
|
|
Term
Describe these stages of malaria parasites:
· Sporozoites
· Hypnozoites
· Merozoites
Trophozoites
· Hepatic schizonts
Gametophytes |
|
Definition
•Sporozoites: from the mosquito enter the circulation and localize in hepatocytes (liver), where they multiply & develop into tissue schizonts (5-15 days).
•Hypnozoites: Latent forms of schizontsà causes clinical illness weeks or months after
•Merozoitesà infectious form that invades RBC.
Trophozoites - immature RBC stage
•Hepatic schizontsrupture, releasing merozoites to invade RBCs (blood cycle)
•If RBCs transmit the disease, there is no tissue stage, since RBC merozoites do not invade the liver.
Gametocytes - male/female form of merozoite that infect naive mosquitoes. |
|
|
Term
__ is the form that infects a naive mosquito |
|
Definition
|
|
Term
____ causes a generally indolent malarial infection (one indisposed to development or action; sluggish). Common in localized areas of the tropics. Clinical attacks may occur years or decades after infection.
|
|
Definition
|
|
Term
Malarial infection caused by ____ has a low mortality rate in untreated adults and is characterized by relapses caused by the reactivation of latent tissue forms (hypnozoites) |
|
Definition
|
|
Term
____ malarial infection is the most dangerous. By invading erythrocytes of any age, sequestering in the vasculature, and producing endotoxin-like products, this species can cause an overwhelming parasitemia, hypoglycemia, and shock with multiorgan failure. |
|
Definition
|
|
Term
2 generalization about antimalarial agents |
|
Definition
1. None of the drugs kill sporozoites (1st forms introduced into the bloodstream by the mosquito)
2. None of the antimalarials is effective against all liver and red cell stages of the life cycle that may coexist in the a given patient.
Complete cure therefore typically requires more than one drug |
|
|
Term
Anti-malaria agents classification are based on? |
|
Definition
target lifecycle of malarial protozoa |
|
|
Term
Name and describe class 1, 2 and class 3 agents. |
|
Definition
Anti-malarial agents Activity:
Class 1: all have action on Asexual RBC stage
•Chloroquine
•Hydroxy-chloroquine
•Quinine, Quinidine
•Mefloquine (reserved)
•Pyrimethamine & Sulfadoxine
•Tetracyclines – weak activity on asexual RBC stage
Class 2: Active on Falciprum in Primary Liver stageand Asexual erythrocyte stage
•Atovaquone-Proguanil
Class 3: Active on Primary (tissue schizont) and latent (hypnozoite) Liver stage, and Gametocyte RBC stage
•Primaquine |
|
|
Term
What is the MOA of Quinolines? |
|
Definition
Interferes with heme metabolism and handling, by binding heme as it is released from hemoglobin utilized by the parasites within red blood cells. If heme, free iron and the resultant reactive oxygen species are not inactivated properly, the parasite suffers oxidative damage. |
|
|
Term
Preferred route of admin and excretion for quinolines. |
|
Definition
route: Oral and parenteral
excretion = hepatic and renal
|
|
|
Term
|
Definition
•Generally narrow safety margin, especially if parenteral.
•GI upset, headache, visual disturbances.
•Cardiovascular effects of hypotension, arrythmias, vasodilation occur in higher levels esp. Mefloquine
•CNS signs of confusion, convulsions and coma.
•Quinolines are oxidants, so if G6PD deficiency esp. Primaquine |
|
|
Term
What is the spectrum of activity of quinolones? |
|
Definition
Class 1 agents = asexual RBC/erythrocytic forms (merozoites, trophozoites and RBC-schizonts) |
|
|
Term
What is the MOA of Diaminopyrimidines and Sulfa combination? |
|
Definition
–Pyrimethamine inhibits the Plasmodium enzyme activity of Dihydrofolatereductase(DHFR) and Thymidylatesynthase(in Plasmodium, these two enzyme activities are in two domains of the same protein molecule)
–Sulfa agent inhibits Dihydropteroatesynthase, which incorporates PABA into dihydropteroic acid during folate synthesis |
|
|
Term
What is the spectrum of activity of Diaminopyrimidines and Sulfa combination? |
|
Definition
class 1 –Slow acting blood schizontocide (asexual RBC form) |
|
|
Term
What is the excretion route of Diaminopyrimidines and Sulfa combination? |
|
Definition
like quinolines- renal and hepatic |
|
|
Term
Give some ADR of Diaminopyrimidines and Sulfa combination. |
|
Definition
•Sulfa component is most responsible for adverse effects seen, including rare but often severe and potentially fatal immune-based dermatological reactions, e.g. Stevens-Johnson syndrome and exfoliative dermatitis, etc. |
|
|
Term
give the 2 types of tetracycline typically used for malaria |
|
Definition
tetracycline or doxycycline |
|
|
Term
What is the MOA of Atovaquone and Proguanil combination? |
|
Definition
–Atovaquone is a ubiquinone (Coenzyme Q) analog that inhibits electron transport and thus decreases ATP synthesis
–Proguanil is a prodrug metabolized to cycloguanil, an inhibitor of the dual function Plasmodium enzyme DHFR / ThymidylateSynthetase (key enzymes in folate dependent pathways & Nucleic Acid metabolism) |
|
|
Term
What is the brand name for Atovaquone and Proguanil combination?
What is the spectrum of activity of Atovaquone and Proguanil combination? |
|
Definition
Malarone
class 2 agents: –Active on the asexual erythrocytic forms
Active on the primary liver stages of P. falciparum only |
|
|
Term
What is the excretion route of Atovaquone and Proguanil combination? |
|
Definition
Hepatic - by CYP 2C family |
|
|
Term
Give some ADR of Atovaquone and Proguanil combination. |
|
Definition
|
|
Term
Explain Mazzotti reaction. |
|
Definition
response of the immune system to disintegration of dead worm forms, which is proportional to the total body burden of parasites; may see fever, headache, dizziness, somnolence, weakness, rash, diarrhea, joint and muscle pain, hypotension, tachycardia and peripheral edem
Treat with corticosteroids |
|
|
Term
which of these is not used against helminth infection:
- • Benzimidazoles
- Pentamidine
- • Diethylcarbamazine
- • Ivermectin
- Praziquantel
- • PyrantelPamoate
|
|
Definition
|
|
Term
Which anti-helminth agent is best for children? |
|
Definition
Benzimidazoles - Mebendazole and Albendazole |
|
|
Term
Which anti-helminth agent is formulated with table salt for prophylaxis |
|
Definition
|
|
Term
Which anti-helminth agent causes paralysis and can lead to swelling of lymph node? |
|
Definition
Ivermectin - binds to GABA receptors |
|
|
Term
Risk assessment for surgical site infections are conducted by he National Research Council (NRC) based on these 4 factors. |
|
Definition
•Microbes at the surgical site
•Presence of a preexisting infection
•Likelihood of contaminating previously sterile tissue during surgery
•Events during and after surgery |
|
|
Term
Name the 4 National Research Council (NRC) wound classifications. |
|
Definition
•Clean
•Clean-contaminated
•Contaminated
•Dirty – pre-existing condition ex. Abscess or necrotic tissue.
•Use therapeutic antibiotics, not prophylaticabx. |
|
|
Term
Describe clean, clean-contaminated and contaminated wounds. When is prophylaxis need? |
|
Definition
Clean wound:
•No acute inflammation or transection of GI, GU, oropharyngeal, biliary, or respiratory tracts
•Elective cases, no technique break – based on technique of surgeon
•Antibiotic prophylaxis is not routinely indicated
Clean – contaminated:
•Controlled opening of a GI, GU,
oropharyngeal, biliary, or respiratory tracts with minimal spillage/minor technique break
•Ex. Elective colon surgery
•Clean procedures performed emergently or with major technique breaks
•Antibiotic prophylaxis is indicated
Contaminated:
•Acute, nonpurulent inflammation present
•Major spillage/technique break during clean-contaminated procedure
•Antibiotic prophylaxis is indicated
|
|
|
Term
The 3 most common pathogens that cause SSI are? |
|
Definition
–Staphylococcus epidermidis
–S. aureus
–Enterococcus spp. |
|
|
Term
2 most common pathogens seen in Infra-inguinal incisions and intracavitary surgery |
|
Definition
|
|
Term
The 3 most common pathogens seen in Surgery on the pharynx, lower GI tract, or female genital tract are? |
|
Definition
–E. coli
–Klebsiellaspp.
–Anaerobic bacteria |
|
|
Term
The majority of SSI abx therapy are agents from _____. |
|
Definition
•1st or 2nd generation cephalosporins satisfy these criteria for MOST operations |
|
|
Term
____ is the most ideal route of administration of antibiotics for SSI prophx? |
|
Definition
•Intravenous route is ideal for most procedures |
|
|
Term
When should prophylactic ABX be given prior to surgery? |
|
Definition
•Prophylactic antibiotics (ex. Beta-lactams)should be given within 1 hour prior to surgical incision
•1-2 hours prior for vancomycin and fluoroquinolones |
|
|
Term
When should re-dosing be considered? |
|
Definition
Intraoperative re-dosing:depends on pharmacokinetics and pharmacodynamics of the drug
- For longer surgeries – you might have to re-administer if drug has short t.5 life to maintain MIC.
- Excessive blood loss during surgery – excessive blood loss would lower MIC, so might have to re-administer
|
|
|
Term
What is the duration for ABX prophx? |
|
Definition
•Prophylactic antibiotics should be discontinued within 24 hours after anesthesia end time
•EXCEPTION – cardiac surgery patients
•Antibiotics should be discontinued within 48 hours after anesthesia end time for cardiac surgery ptns.
•Prolonged administration increases the risk of C. diff and the development of antimicrobial resistant pathogens |
|
|
Term
Why should duration for ABX prophyx be limited? |
|
Definition
•Prolonged administration increases the risk of C. diff and the development of antimicrobial resistant pathogens |
|
|
Term
For Coronary Artery Bypass Graft (CABG), other Cardiac, or Vascular Surgery, give the recommended therapy, alternative agent, and agents used in case of allergy to recommended agent. What bugs are common? |
|
Definition
•Recommended agent:
•Cefazolin
•Alternative agent: Cefuroxime– 2nd gen
•If β-lactam allergy
•Clindamycin
•Vancomycin 1 g IV (or 10 – 15 mg/kg |
|
|
Term
For Hip/Knee Arthroplasty, give the recommended therapy, alternative agent, and agents used in case of allergy to recommended agent. What bugs are common? |
|
Definition
•Recommended agent:
•Cefazolin
•Alternative agent: Cefuroxime– 2nd gen
•If β-lactam allergy
•Clindamycin |
|
|
Term
For colon surgery, give the recommended therapy, alternative agent, and agents used in case of allergy to recommended agent. What bugs are common? |
|
Definition
•Recommended - use cephalosporins that target anaerobes = cephamycins
•Cefotetan
•Cefoxitin
•Ampicillin/Sulbactam (Unasyn)
•Ertapenem
•
•Alternative
•Cefazolin or cefuroxime + metronidazole
•β-lactam allergy
•Clindamycin PLUS
•Aminoglycoside
or
•Fluoroquinolone
or
•Aztreonam
•Metronidazole
• PLUSfluoroquinolone |
|
|
Term
For hysterectomy, give the recommended therapy, alternative agent, and agents used in case of allergy to recommended agent. What bugs are common? |
|
Definition
Hysterectomy prophylaxis: G+ and anaerobes
•Recommended
•Cefazolin
•Cefotetan
•
•Alternative
•Cefoxitin
•
•β-lactam allergy
•Clindamycin PLUS
•Aminoglycoside
• or
•Fluoroquinolone
• or
•Aztreonam
•Metronidazole PLUS fluoroquinolone |
|
|
Term
When can prophylaxis be given for infective endocarditis? For how long? |
|
Definition
High risk of mortality and morbidity |
|
|
Term
What type of patients need infectious endocarditis prophx? |
|
Definition
•Prosthetic cardiac valves or prosthetic material used for cardiac valve repair
•Previous history of IE
•Cyanotic heart disease (CHD)
•Unrepaired CHD or repaired with residual defects
•Congenital heart defect repaired with prosthetic material for the first 6 months after the repair
•Select cardiac transplant patients
Also patients undergoing dental procedure involving perforation of oral mucosa and manipulation of gingival tissues or periapical region of teeth. |
|
|
Term
Prophylaxis is no longer recommended for the 3 GI/GU procedures. |
|
Definition
•Transesophageal echocardiogram
•Endoscopy
•Colonoscopy |
|
|
Term
Give the prophylaxis regimen for IE. Give doses and frequency. What if allergy? |
|
Definition
•Oral
•Amoxicillin 2 g PO single dose
•Unable to take PO
•Ampicillin 2 g IM or IV single dose
•Cefazolin or ceftriaxone 1 g IM or IV single dose
Allergy to penicillins or ampicillin:
–Cephalexin 2 g PO single dose
–Clindamycin 600 mg PO, IM, or IV single dose
–Azithromycin or clarithromycin 500 mg PO single dose
–Cefazolin or ceftriaxone 1 g IM or IV single dose
|
|
|
Term
|
Definition
Pharmacodynamics: relationship between the drug concentration and the antibacterial effect, based on MIC levels. |
|
|
Term
Differentiate between pharmacodynamics and pharmacokinetics. |
|
Definition
Pharmacodynamics: relationship between the drug concentration and the antibacterial effect, based on MIC levels i.e. what drug does to body.
Pharmcokinetics: While pharmacokinetics is the time course of the antimicrobial effects at the site of infection i.e. what body does to drug.
|
|
|
Term
What are 3 benefits of pharmacodynamics? |
|
Definition
• May assist in treatment selection
• Gives us better information on drug dosing - Increase efficacy
• Decrease toxicity and resistance |
|
|
Term
What are 2 limitations of pharmacodynamics? |
|
Definition
• Data not available for all drugs/infections.
• Relies on in vitro and animal modeling. |
|
|
Term
Compare and contrast time and concentration-dependent killing. |
|
Definition
Time-dependent: beta-lactams and glycopeptide
• As concentration increases, ability to kill is stagnant
• but as time increases, ability to kill increases.
Concentration-dependent: Aminoglycosides and flouroquinolones
• As time increases, ability to kill stays the same.
• But as concentration increases, ability to kill is increases |
|
|
Term
Define post-antibiotics effect. |
|
Definition
Post-antibiotic Effect: continued suppression of bacterial growth for prolonged periods when drug concentrations fall below the MIC of the bacteria. ex aminoglycosides.
Possible mechanisms of Post-antibiotic Effect: Continued persistence of the drug at the bacteria’s drug-binding site after concentrations are below MIC. |
|
|
Term
What 5 factors play a role post-antibiotics effect? |
|
Definition
•The type of microorganism
•The inoculum size
•The type of antibiotic
•The concentration of antibiotic
•Duration of exposure |
|
|
Term
Give the 3 main pharmacodynamics indices used for drug characterizations. |
|
Definition
• Peak/MIC - ex. aminglycosides
• AUC/MIC - vancomycin & Fluoroquinolones
• 40-50%Time above MIC - beta lactams |
|
|
Term
Which pharmacodynamic index best describes the activity of the following drugs: beta-lactams, fluoroquinolones, glycopeptides, aminoglycosides |
|
Definition
• Peak/MIC - ex. aminglycosides
• AUC/MIC - vancomycin (>=400) & Fluoroquinolones (>=125 for G- and >=33.7 for G+)
• 40-50%Time above MIC - beta lactams |
|
|
Term
Give 3 dosing strategy to meet target pharmacodynamics goals for multi-drug resistant pathogens? |
|
Definition
•More frequent dosing
•Extended infusion
•Continuous infusion |
|
|
Term
Give 3 pros and 3 cons of prolonged/continuous infusion |
|
Definition
Pros of Prolonged/Continuous Infusion:
•Increased drug efficacy with PK/PD principle
•Clinical benefit, especially among critically ill patients
•Cost saving from the reduction in total daily dose.
Cons of Prolonged/Continuous Infusion:
•Line access is limited for patients in ICU.
•Not all medications can be used as continuous infusion due to the stability issue.
•Concentrations greater than MIC may not be achieved for multi-drug resistant pathogens. |
|
|
Term
How do you monitor efficacy for Vancomycin. What is the target AUC/MIC? |
|
Definition
Trough = efficacy and decrease resistant
Target AUC/MIC |
|
|
Term
What is the target Peak/MIC for aminoglycosides? |
|
Definition
8-10 times MIC of bacteria |
|
|
Term
Give the 4 risk factors for nephrotoxicity from vancomycin. |
|
Definition
• Advancing age
• Prolonged therapy (> 3 weeks)
• Sustained troughs (> 20 mg/dL) à recommended trough levels is 15-20 mg/dL
• Concomitant nephrotoxins |
|
|
Term
What is the loading dose for vancomycin?
When do you use loading dose |
|
Definition
25-30 mg/kg
Use loading dose if serious infection due to MRSA:
•CNS infection
•Endocarditis
•Pneumonia
•Bacteremia, Sepsis
•Osteomyelitis
|
|
|
Term
What is the starting dose vancomycin.
what weight do you use to calculate dose? |
|
Definition
15-20mg/kg
Actual body weight |
|
|
Term
Case study: 25 yo male is admitted to the ICU due to suspected hospital-acquird pneumonia. Ht: 170 cm,. Wt: 70 kg, Scr 0.6. Please calculate vancomycin regimen based on “general dosing” method |
|
Definition
•Use loading dose, since HAP is a serious infection that is often due to MRSA (late onset HAP).
•Also, patient is in ICU
•Loading dose dosage: 25-30 mg/kg
•LD * Actual BW à 25-30mg/kg * 70kg = 1750 mg – 2100 mg
•So pick either 1750mg or 2000 mg (never over 2000 mg or 2g) à can increase dose in 250mg increments.
•Infusion is 1g per hr, so it will take 2 hours to infuse either dose (which is picked).
•Starting dose: 15-20mg/kg ß if ptns does not meet requirements for starting dose
•SD * ABW = 1050mg – 1400 mg
•Can use 1250 mg IV over 1.5 hrs Q8H (q8H since ptn has good Scr). |
|
|
Term
what is the formula for calculating CrCl, IBW and Adjusted body weight? |
|
Definition
•CrCl = (140-age)x IBW/(72x Scr)
•For female: x 0.85
IBW = 45.5kg + 2.3kg (inches above 5ft)
•AjBW = IBW + 0.4kg (TBW-IBW)
|
|
|
Term
What is the target trough level for MRSA with vancomycin? |
|
Definition
|
|
Term
When do you calculate trough level for vancomycin? Aminoglycosides? |
|
Definition
Vancomycin = before 4th dose (when steady state occurs)
Aminoglycosides = |
|
|
Term
Vancomycin 1 g IV q12h for Pneumonia, trough 12 mcg/mL. What is your recommendation based on this level? |
|
Definition
–Target goal: 15-20, subtherapeutic level
–Proportionately increase dose
•Total daily dose: 2000 mg, Vt: 12 mcg/mL
•2000:12= x: 15-20
•x→ 2500 mg/day – 3333 mg/day
•Choose 3000 mg/day
•1500 mg IV over 90 min infusion q12h
–Increase dosing frequency
•1 g IV over 60 min infusion q8h
•2000:12 = 3000: x, x= 18 mcg/mL |
|
|
Term
How do you dose adjust for vancomycin or AGs if trough level is low? High trough levels? |
|
Definition
•If trough is low:
•Proportionately increase dose, or
•Increase dosing frequency
•If trough is high:
•Decrease dose, or
•Dose less frequently |
|
|
Term
|
Definition
Redman syndrome
Nephrotoxicity
Ototoxicity |
|
|
Term
How do you check for efficacy for aminoglycosides? |
|
Definition
•Measure trough concentration (Ctr) at steady state and peak concentration (Cpk)
•Check trough level immediately before dose
•Measure peak 30min after a 30min infusion. |
|
|
Term
What are the peak concentration for Gentamicin/Tobramycin and Amikacin for patients with:
• Endocarditis (synergy)
• Serious Infection
• Urinary Tract Infection
• Life threatening infection or pneumonia |
|
Definition
Gentamicin/Tobramycin and Peak concentration levels: trough level = 0.5 - less than 2 mcg/mL
•Life threatening infection or pneumonia: 8-10 mcg/mL
•Serious Infection: 6-8 mcg/mL
•Urinary Tract Infection: 4-6 mcg/mL
•Endocarditis (synergy): 3-4 mcg/mL
Amikacin concentrations: <8 mcg/mL
•Life threatening infection or pneumonia: 25-35 mcg/mL
•Serious Infection: 20-25 mcg/mL
•Urinary Tract Infection: 15-20 mcg/mL
•Endocarditis (synergy): - |
|
|
Term
What are the target trough for the AGs? |
|
Definition
Gentamicin/Tobramycin target trough = 0.5 - less than 2 mcg/mL
Amikacin target trough: 4 mcg/ml (at least <8 mcg/mL) |
|
|
Term
Give 4 rationales for use of extended-interval dosing for AGs. |
|
Definition
•Concentration-dependent killing
•Post-antibiotic effect
•Seen with Staph and Gram negatives
•When bacterial growth is inhibited even after drug concentrations are below the MIC
•Typically 2-7 hours
•Dependent on peak concentrations
•Prevents adaptive resistance
•Prevent down-regulation of transport
•Less tissue accumulation
•Allows for low or undetectable concentrations
•Drug can diffuse out of deep tissue compartments (saturable uptake)
•Less risk of toxicity (ear, kidney) |
|
|
Term
Name 6 criteria for exclusion from Extended-interval dosing. |
|
Definition
•Pregnancy –volume of distribution changes
• Burns > 20% - volume of distribution changes and high metabolic condition (high clearance)
• Cirrhosis/ascites - fluid overload
•ClCr <30 ml/min – fluid overload
• Dialysis – fluid overload
• Cystic fibrosis - volume of distribution changes and high metabolic condition (high clearance) |
|
|
Term
|
Definition
•Nephrotoxicity: high trough, prolonged therapy, advanced age and dehydration, additional nephrotoxic agents (i.e.; Ampho B, vancomycin).
•Ototoxicity: high peak, prolonged therapy, advanced age and dehydration, additional ototoxic agents (i.e.; loop diuretics).
•Neuromuscular paralysis: after anesthesia or muscle relaxants. |
|
|
Term
Compare aminoglycoside traditional vs extended-interval dosing |
|
Definition
Traditional dosing = ideal body weight
extended-interval dosing = total body weight or Nomogram |
|
|
Term
Name the 3 endemic mycoses. |
|
Definition
|
|
Term
name the 3 opportunistic mycoses |
|
Definition
|
|
Term
Name the 4 risk factors for fungal infections. |
|
Definition
- Widespread use of potent broad-spectrum antimicrobial agents - kills microbiome that normally prevents fungal growth
|
|
|
Term
Name 2 species of candida that are resistant to fluconazole. |
|
Definition
C. glabrata (dose dependent) & C. krusei |
|
|
Term
What is the best lab test for detection of C. albicans? |
|
Definition
· Culture
· Germ tube
o + identification of C. albicans within 1-2 hours
o HIV-infected individuals: C. dubliniensis
· Pepetide nucleic acid (PNA) fluorescence in situ hybridization (FISH)
o Results available within 90 minutes
o Sensitivity: 99-100%, specificity: 100% for C. albicans |
|
|
Term
Give the treatment regimen for treatment of candida. Give the 1st line agents and alternate treatments. |
|
Definition
|
|
Term
What is the 1st and 2nd line empiric treatment for aspergilosis? |
|
Definition
1st line: Voriconazole
2nd line: Lipid form Amphotericin B |
|
|
Term
This two azoles may be active against C. glabrata and C. krusei |
|
Definition
Itraconazole and Voriconazole |
|
|
Term
Give the salvage therapy for aspergilosis: monotherapy agent and combination agents. |
|
Definition
Salvage Monotherapy = Posaconazole
Salvage combination = Voriconazole + Echinocandin OR Lipid form Amphotericin B + Echinocandin |
|
|
Term
Halo sign seen in a CT scan is unique to this fungal infection. |
|
Definition
|
|
Term
This agent class should never be used for Cryptococcus infection. Why? |
|
Definition
Echinocandin - MOA = inhibition of enzyme 1,3 beta glucan synthase which is needed to make fungal cell wall.
Cryptococcus lack use a different enzyme and different glucan linkage to make cell wall. |
|
|
Term
Give the treatment regimen for Cryptococcus infection:
mild-to-moderate pulmonary
Severe pulmonary
CNS |
|
Definition
o Mild-to-moderate Pulmonary
o Fluconazole for 6 months
o Alternatives: itraconazole, amphotericin B
Severe pulmonary = Treat like CNS disease
· CNS
o Induction: Amphotericin B + flucytosine x 2 wks, then ± fluconazole x 8wks
o Alternatives
· Monotherapy: lipid form amphotericin B
o Maintenance therapy (for AIDS patients)
o Fluconazole until CD4 > 200 /µl |
|
|
Term
Give the treatment regimen for Histoplasmosis infection:
Mild-to-moderate infection and moderate-to-severe infections. |
|
Definition
Mild to moderate disease Treatment is usually not needed Symptoms > 1 month: itraconazole200 mg tid x 3 days, then 200 mg bid Acute pulmonary histoplasmosis: 12 weeks Chronic cavitary pulmonary histoplasmosis: at least I year Moderately severe to severe Amphotericin B x1-2 weeks, then itraconazole 200 mg tid x 3 days, then 200 mg bid Acute pulmonary histoplasmosis: 12 weeks Chronic cavitary pulmonary histoplasmosis: at least 1 year
Methylprednisolone x 1-2 weeks for patients with acute respiratory complications (hypoxemia, significant respiratory distress) |
|
|
Term
Give types of fungal infection where steroid are recommended for treating fungal infections. What type of corticosteroid? |
|
Definition
Histoplasmosis = methylprednisolone x 1-2 weeks for patient with acute respiratory complications |
|
|
Term
Give the treatment regimen for Blastomycosis infection:
Mild-to-moderate infection, life-threatening, or CNS infections. |
|
Definition
Pulmonary of disseminated disease (non-CNS)
Mild to moderate = Itraconazole 200 mg PO tid x 3days, then 200 mg qdaily or bid x 6-12 months
Life threatening = Amphotericin B for 1-2 weeks, then itraconazole 200 mg tid x 3days, then 200 mg qdaily or bid x 6-12 months
CNS disease
Amphotericin B (Lipid formulation is preferred) x 4-6 weeks, then Azole (fluconazole, itraconazole, or voriconazole) x 12 months OR resolution of CSF abnormalities
|
|
|
Term
____ is the most preferred agent for Blastomycosis and histoplasmosis. |
|
Definition
|
|
Term
Give the risk factors for Coccidioidomycosis infection. |
|
Definition
o Race (Filipinos > African-American > Native American > Hispanics > Asians)
o Pregnancy (especially 2nd or 3rd trimester)
o Compromised immune system (AIDS pts, on steroids, immunosuppressive agents, chemotherapy)
o Male gender
o Neonates
o Patients with B or AB blood types |
|
|
Term
Give the treatment regimen for Coccidioidomycosis infection:
Primary respiratory or disseminated (NON-CNS) infection |
|
Definition
· Asymptomatic = NO treatment
· Primary respiratory or disseminated (NON-CNS) infection
o Azole antifungal (usually fluconazole)
o Amphotericin B formulation
ü Duration: month-to-years until clinical improvement and stabilization, some cases require lifelong suppressive therapy
|
|
|
Term
Give the treatment regimen for Coccidioidomycosis infection: Disseminated CNS disease. |
|
Definition
· Disseminated CNS disease
o Fluconazole (for life)
o Itraconazole (for life)
o Amphotericin B intrathecal therapy ± fluconazole or itraconazole |
|
|
Term
Which antifungal has the best CNS penetration and which has the worst? |
|
Definition
Best = Lipid Amphoterocom B > Fluconazole
Worst = Traditional amphotericin B < Itraconazole |
|
|
Term
Give 4 monitoring parameters for azoles. |
|
Definition
- QT prolongation
- Visual problems
- Hepatic/ renal problems
- CYP drug interaction
|
|
|
Term
Which echinocandin should hepatic function be monitored? |
|
Definition
|
|
Term
What are 5 monitoring parameters for AmB? |
|
Definition
- Nephrotoxicity
- infusion-related issues ex. fever, chills and tachypnea
- Hypokalemia and hypomagnesemia
- Anemia
- Headache/N/V, malaise, weight loss, thrombophlebitis
|
|
|
Term
How can nephrotoxicity be prevented with AmB? |
|
Definition
· Hydration + Sodium repletion: infuse NS 0.5 L before and after Amphotericin B dose
|
|
|
Term
This class of antifungals should never be used as a monotherapy due to increased risk of resistance. |
|
Definition
|
|
Term
WHat are 4 monitoring parameters for Flucytosine? |
|
Definition
- GI distress (Nausea/vomiting/diarrhea)
- Hepatic/renal function
- Bone marrow toxicity: CBC (Leukopenia, thrombocytopenia)
- Drug levels (for safety as well as efficacy)
|
|
|
Term
Write the brand names for:
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Caspofungin
Micafungin
Anidulafungin
AmB colloidal dispersion
AmB lipid cmplex
AmB deoxycholate
Liposomal AmB
|
|
Definition
Fluconazole = Diflucan
Itraconazole = Sporanox
Voriconazole = Vfend
Posaconazole = Noxafil
Caspofungin = Cancidas
Micafungin = Mycamine
Anidulafungin = Eraxis
AmB colloidal dispersion = Amphotec
AmB lipid c0mplex = Abelcet
AmB deoxycholate = Fungizone
Liposomal AmB = Ambisome |
|
|
Term
Differentiate between sepsis, severe sepsis and septic shock. |
|
Definition
· Sepsis: 2 or more SIRS criteria + infection
ptns needs antibiotics therapy
· Severe Sepsis: Sepsis + organ dysfunction, hypoperfusion, or hypotension (Systolic BP < 90 mm Hg or > 40 mm Hg reduction without another cause)
o Needs antibiotics
o Fluid resuscitation
· Septic Shock: Severe sepsis + hypotension despite adequate fluid resuscitation. |
|
|
Term
List the 4 criteria for Systemic Inflammatory Response Syndrome (SIRS). |
|
Definition
- o Heart rate > 90 beats/minute
- o Respiratory rate > 20 breaths/minute or PaCO2 < 32 mm Hg
- o Temperature > 38oC (100.4oF) or < 36oC (96.8oF) à Hypothermia or Hyperthermia
- o WBC > 12,000/mm3, < 4,000/mm3, or > 10% bands
|
|
|
Term
Give factors that increased the number of patients with sepsis. |
|
Definition
o Immunocompromised patients (e.g.: on chemotherapy or steroids)
o Invasive devices OR procedures (e.g.: urinary catheter, intravascular tube, wound drainage)
o Resistant pathogens (in the hospital)
o Aging population |
|
|
Term
Give the 3 common sites of infection that leads to sepsis. Name the common pathogens. which is the most common site? |
|
Definition
· Respiratory tract (21-68%) <-- most common site
· Intraabdominal space (14-22%)
· Urinary tract (14-18%) |
|
|
Term
Name the common pathogens that cause sepsis. Which are the most common? |
|
Definition
|
|
Term
Name the 7 factors that increases mortality in sepsis. |
|
Definition
o Shock
o Rapid fatal underlying disease (e.g., neoplasm, human immunodeficiency virus (HIV) disease)
o Age > 70 years
o Gram-negative (e.g., Pseudomonas sp.) OR yeast infection
o Inappropriate antibiotic therapy
o Leucopenia, severe thrombocytopenia, bleeding
o Multiple organ failure |
|
|
Term
Name the 2 ways sepsis can be diagnosed. |
|
Definition
§ Obtain appropriate cultures before starting antibiotics (Do not significantly delay antimicrobial administration due to the cultures)
• Obtain 2 or more blood cultures
At least one percutaneous blood culture
• One blood culture from each vascular access device (> 48 hours)
• Culture other sites (as clinically indicated)
§ Perform imaging exams to confirm and sample any source of infection. |
|
|
Term
Give the pro- and anti-inflammatory mediators in sepsis. |
|
Definition
1. Release pro-inflammatory mediators to eradicate microorganisms
· TNF-α, IL-1, IL-6, IL-8
· Damage to host tissue
2. Release anti-inflammatory mediators
· IL-1RA, IL-4, IL-10
· Leukocytes activation |
|
|
Term
Give the treatment regimen for sepsis, severe sepsis and septic shock. |
|
Definition
Goal: (for the first 6 hours) § Infection source control: Identify infection source
§Treatment: § Fluid resuscitation (immediately) § Vasopressor therapy
§ Antibiotic therapy (within 1 hour)
|
|
|
Term
Give the duration the duration of treatment for sepsis. |
|
Definition
|
|
Term
For sepsis treatment, describe the:
fluid resuscitation
Cardiovascular support
inotropic therapy
|
|
Definition
Fluid therapy: Crystalloids (1L over 30 minutes) = Normal saline OR lactated ringers
Cardio (use vasopressors) = Norepinephrine or dopamine(1st line) > Epinephrine (alternative 1st line) > Phenylephrine > vasopressin
Inotropic = dobutamine |
|
|
Term
When should steroids be used in treating sepsis? Give examples of the types of steroids. |
|
Definition
Use steroid only if poor fluids and vasopressor response to septic shock
Hydrocortisone (is preferred) or Fludrocortisone 50 mcg Qdaily |
|
|
Term
What type of blood product can be given to sepsis patients? Which is not recommended. |
|
Definition
Red Blood Cells
Fresh Frozen Plasma or
Platelet administration
Never give erythropoetin |
|
|
Term
What is the blood glucose range recommended for sepsis patients? |
|
Definition
140-180 mg/dL (goal is 150 mg/dL) |
|
|
Term
Give examples of the 3 groups of herpes virus. |
|
Definition
1) Alpha – HSV1, HSV2, and varicella (HSV3)
2) Beta – cytomegalovirus
3) Gamma – Epstein Barr virus |
|
|
Term
Describe the 3 different presentations of herpes zoster. |
|
Definition
A. Prodrome
1. Continual or intermittent burning, tingling, loss of sensation or sharp knifelike, deep boring pain
2. May have headache, malaise, photophobia, fever
3. Occurs a few hours to several days before rash
B. Acute
1. Pain occurring along dermatomes appears first (ranges from mild itching or tingling to severe pain) à unilateral occurrences on dermatome
2. Most common sites: chest, abdomen, neck, and eye
3. Clear vesicles appear within 5 days
4. Rash is characteristically unilateral
5. Lesions become pustular and crusty within 14 days
C. Postherpetic neuralgia(chronic form)
1. Defined as pain that persists more than 120 days after the onset of rash or after cutaneous healing
2. Described as a stabbing, burning, aching, electric shock-like pain
3. Incidence and duration are directly correlated with the patient’s age
4. Affected areas are sensitive to heat and cold |
|
|
Term
Give the 3 agents used for treatment of herpes zoster. |
|
Definition
famciclovir, acyclovir, or valacyclovir (FAV)
|
|
|
Term
what is the duration for herpes zoster treatment? |
|
Definition
|
|
Term
Why is steroid used for treatment for herpes zoster? |
|
Definition
Corticosteroids reduce acute symptoms and accelerate the rate of cutaneous healing --> does not work for postherpetic neuralgia |
|
|
Term
Give the systemic agents used to treat postherpetic neuralgia. |
|
Definition
1. TCAs (nortriptyline or amitriptyline) may prevent or reduce postherpetic neuralgias
2. Opioids w/ acetaminophen (hydrocodone, oxycodone), tramadol
3. Gabapentin, pregabalin
4. Lidocaine 5% patch (up to 3 for max of 12 hours)
5. Capsaicin Cream (Zostrix®)
6. Note – steroids do NOT help prevent postherpetic neuralgia |
|
|
Term
Give and describe the prevention methods for herpes zoster. |
|
Definition
A. Varicella vaccine – for chicken pox
1. Live, attenuated
2. Recommended for healthy children / adults
3. Two dose regimen (first 12-15 months, then 4-6 years)
4. 70-95% effective
B. Herpes zoster vaccine (Zostavax®)
1. Live, attenuated
2. Same strain as childhood vaccine, but 14-fold higher dose of organism (1,350 versus 19,000 units)
3. Do NOT give to children
4. Lasts ~ 4 years
5. Not completely effective (61% reduction in cases)
6. Recommended for:
a. Immune competent
b. Age >60
7. Is NOT for treatment |
|
|
Term
Which herpes zoster vaccination is only for adults? |
|
Definition
Herpes zoster vaccine (Zostavax®) |
|
|
Term
Name the at-risk group for CMV. |
|
Definition
A. Newborns
B. HIV (AIDS) – primarily retinitis
C. Stem cell / solid organ transplant |
|
|
Term
Give the immunization for CMV. |
|
Definition
|
|
Term
Give the prevention therapy for CMV. |
|
Definition
Valganciclovir, possibly ganciclovir |
|
|
Term
Give the 1st line treatment for CMV. |
|
Definition
Ganciclovir and Valganciclovir are first line treatment options. |
|
|
Term
Give the alternate agents if CMV is resistant to 1st line agents. |
|
Definition
Foscarnet
cidofovir
CMV Immunoglobulin |
|
|
Term
Describe the influenza virus. Which strain is most severe? |
|
Definition
1. Influenza viruses are classified as A, B, and C
a. A and B are most common and most severe
b. Immunity to C develops in childhood
2. Influenza A is further classified by surface glycoproteins
a. Hemagluttin (Hx) – involved in host cell binding prior to viral entry
b. Neuramidase (Nx) – necessary for viral release and propagation |
|
|
Term
Who should receive influenza vaccination? |
|
Definition
Everyone = universal vaccination |
|
|
Term
Recommend a vaccination schedule for first timers between the age of 6months to 8 years. |
|
Definition
Trivalent inactivated vaccine (TIV) via IM administration - get 2nd dose 4 weeks later |
|
|
Term
Give and describe the 2 types of influenza vaccination available. Which is IM and which is a spray. |
|
Definition
Trivalent inactivated vaccine (TIV) = IM injection = or high dose version (Fluzone) can be given to any including those over 65 yrs old
Live attenuated vaccine (LAIV) (FluMist®) = nasal spray = only for 2-49 years old.
|
|
|
Term
What is fluzone high dose classified as? |
|
Definition
Trivalent inactivated vaccine (TIV) |
|
|
Term
Give the pharmacological prophylaxis for influenza. What are their brand names? Which one is oral and which is by inhalation? |
|
Definition
Oseltamivir (Tamiflu) = oral
Zanamivir (Relenza) = inhalation
Peramivir (Cyclopentane) |
|
|
Term
Name the 3 types of STI that causes urethritis/cervicitis. |
|
Definition
|
|
Term
Name the 3 types of STI that causes genital lesions. |
|
Definition
|
|
Term
Name the 3 types of vaginosis infection. |
|
Definition
|
|
Term
Give the #1 and #2 most reported STI in the US. |
|
Definition
Chalmydia = #1
Gonorrhea = #2 |
|
|
Term
Describe the treatment for gonorrhea:
Uncomplicated cervicitis, urethritis, pharyngitis gonorrhea
gonorrhea with severe cephalosporin allergy
Disseminated gonorrhea infection |
|
Definition
2 grams Azithromycin PO x 1 dose + test of cure
|
|
|
Term
Always treat gonorrhea as if co-infected with ______ |
|
Definition
|
|
Term
Describe the organism that causes chlamydia. |
|
Definition
Chlamydia trachomatis - an obligate intracellular organism |
|
|
Term
Describe the organism that causes gonorrhea. |
|
Definition
Neisseria gonorrhea - a gram - diplococcus |
|
|
Term
Describe the treatment principle for Chlamydia. What if patient is pregnant? |
|
Definition
General infection: Azithromycin 1 gram PO x 1 dose or Doxycycline 100 mg PO BID x 7 days
Alternative:
Erythromycin x 7 days or Ofloxacin/Levofloxacin x 7 days)
If Pregnant:
Azithromycin 1 gram PO x 1 dose or Amoxicillin 500mg PO TID x 7 days
Alternative: Erythromycin x 7 days (avoid erythromycin estolate) |
|
|
Term
“Asymptomatic, with positive serologic tests” describes which stage of syphilis? |
|
Definition
|
|
Term
“Inflammation of any organ system and Gummas” describes which stage of syphilis? |
|
Definition
|
|
Term
“one or more, painless, nontender, papules in genital area; is highly contagious” describes what stage of syphilis? |
|
Definition
Chancre = stage 1 or primary stage |
|
|
Term
“ impotence, bladder disturbances, fecal incontinence, peripheral neuropathy, Hemiplegia, hemiparesis, seizures, speech disturbances postural instability” describes what stage of syphilis? |
|
Definition
|
|
Term
“Mucocutaneous eruptions due to hematogenous and lymphatic spread” describes what stage of syphilis? |
|
Definition
Stage 2 or secondary stage |
|
|
Term
Describe the treatment and alternative treatments for the different stages of syphilis. |
|
Definition
Late Latent or Tertiary:
· Penicillin G benzathine 2.4 MU IM QWeek x 3 weeks
· Alternative: Doxycycline 100 mg BID X 28 d
Tetracycline 500 mg QID X 28 d
Alternative: Procaine PCN 2.4 million units IM Daily PLUS Probenecid 500 mg QID for 10-14 d
|
|
|
Term
Give the 2 types of genital herpes and which is most common. |
|
Definition
a. HSV-1: 30% of 1st episode cases; recurrence less frequent
b. HSV-2: most cases of recurrent genital herpes |
|
|
Term
Describe the treatment principle for genital herpes. |
|
Definition
a. Oral Antivirals
1. Acyclovir (Zovirax) – 3-5 times per day
2. Famciclovir (Famvir) - TID
3. Valacyclovir (Valtrex) - BID
4. NOTE: many regimens and dosing schedules
5. Topical therapy has no role in genital herpes infection
b. Duration
1. 1st episode ® 7-10 days
2. Recurrent episodes ® 1-5 days
c. Daily suppressive therapy = Recommended for patients with >6 episodes per year
2. Also effective at decreasing transmission via asymptomatic viral shedding
d. Severe disease = Acyclovir 5-10 mg/kg IV Q8hrs x 2-7 days or until clinical resolution
Followed by oral antiviral therapy to complete 10 days total therapy |
|
|
Term
What is the treat for severe genital herpes? |
|
Definition
1. Acyclovir 5-10 mg/kg IV Q8hrs x 2-7days or until clinical resolution
Followed by oral antiviral therapy to complete 10 days total therapy |
|
|
Term
Name and describe the vaccination for HPV infection. |
|
Definition
1. Vaccine types:
a. Gardisil® - Quadrivalent; protects against 6, 11, 16, 18
b. Cervarix® - Bivalent; protects against 16 and 18 |
|
|
Term
Only this types of vaginosis is considered an STI. |
|
Definition
|
|
Term
Give the treatment therapy for:
Bacterial vaginosis
Trichomoniasis
Vulvovaginal candidiasis |
|
Definition
Bacterial vaginosis = Metronidazole or Clindamycin (PO if pregnant)
Trichomoniasis = Metronidazole BID x 7 days or Tinidazole single dose
Vulvovaginal candidiasis = 150 mg Fluconazole x 1 dose or Intravaginal azoles (Miconazole or Clotrimazole)
If pregnant use topical azoles |
|
|
Term
Describe the 3 phases of HIV infection. |
|
Definition
o 2-4 weeks after exposure
o 50% have symptoms (nonspecific, flu-like illness)
o Few present at this stage
· Clinical Latency
o Asymptomatic
o Is NOT virologic latency – virus continues replicating, but no symptoms
o This is the ideal time to start treating.
· AIDS
o patients commonly present secondary to an opportunistic infection
|
|
|
Term
What is the definitive diagnosis for AIDS? |
|
Definition
CD4+<200or AIDS defining condition |
|
|
Term
Name the 2 backbone agents in ART. |
|
Definition
2 NRTIs - one nucleotide (Tenofovir) and one Nucleoside (Emtricitabine)
In combination as Truvada |
|
|
Term
Give the ART make up for:
· NNRTI based
· The 2 Protease inhibitors- based
· Integrase strand transfer inhibitor based
· Pregnant women |
|
Definition
· NNRTI based = Tenofovir + Emtricitabine + Efavirenz
· The 2 Protease inhibitors- based = Tenofovir + Emtricitabine + Atazanavir-Ritonavir
· Integrase strand transfer inhibitor based: Tenofovir + Emtricitabine + Raltegravir
· Pregnant women: Ritonavir-Lopinavir + Zidovudine + Lamivudine |
|
|
Term
|
Definition
single tablet combination: Tenofovir + Emtricitabine + Efavirenz |
|
|
Term
These are considered “protease-sparing.” Why? |
|
Definition
NNRTI; they have less GI and CNS symptoms |
|
|
Term
This agent should be avoided in the 1st trimester and can cause psychiatric conditions. |
|
Definition
|
|
Term
_____is a NNRTI used in a single tablet in combination called Complera and is used only when HIV RNA is _____. |
|
Definition
Rilpivirine - use when HIV RNA < 100,000 |
|
|
Term
Aside from Efavirenz, name the 2 other acceptable NNRTI |
|
Definition
Rilpivirine - given (in combination as Complera) when HIV RNA load is <100,000.
Nevirapine - avoid in healthy patients due to hepatoxicity |
|
|
Term
This NNRTI should be avoided in healthier HIV patients (female with CD4+ > 250 and male > 400) |
|
Definition
|
|
Term
Which PI causes hyperlipidemia and increases risk of cardiovascular disease? |
|
Definition
Fosamprenavir - a prodrug |
|
|
Term
Which PI is doses once daily and causes asymptomatic hyperbilirubinemia? |
|
Definition
|
|
Term
Which PI has a sulfa moiety and can cause rash, hyperglycemia, N/V and hepatitis? |
|
Definition
|
|
Term
Which PI causes hyperlipidemia but is preferred for pregnant women. |
|
Definition
|
|
Term
|
Definition
|
|
Term
Give 4 pharmacist roles in ensuring optimal treatment for HIV. |
|
Definition
1. Educate about drug toxicity and interactions
2. Help educate patient about medication assistance programs
3. Help with picking best regimen, monitoring and modification of therapy.
4. Help improve compliance and adherence. |
|
|
Term
Describe the 3 types of monitoring parameter for HIV infection. When should measures be taken? |
|
Definition
1. HIV RNA - a.k.a. viral load
b. Reflects rate of progression of disease
c. Measure at baseline and every 3-4 months
d. Should decrease dramatically with therapy
2. CD4+
a. Current immune status – use to determine needs for opportunistic infection prophylaxis
b. Measure at baseline and every 3-4 months
c. Should increase with successful treatment
3. Resistance testing
a. Genotype (preferred method)
i. Recommended at baseline in all patients (transmission of resistant virus 5-16%)
ii. Obtain prior to modifications in drug therapy
b. Phenotype (in addition to genotype)
i. Similar effectiveness to genotype but more expensive, takes longer
Can use both in combination in complex patients |
|
|
Term
Which HIV monitoring parameter is used to determine needs for opportunistic infection prophylaxis by measuring current immune status? |
|
Definition
CD4+
Measure every 3-4 months at baseline |
|
|
Term
Which HIV monitoring parameter is used to determine disease rate of progression? |
|
Definition
HIV RNA or viral load
Measure every 3-4 months |
|
|
Term
Give the 2 endpoints for suppressing viral load and the tentative dates. |
|
Definition
HIV RNA <400 copies at 24 weeks and <48 cells at 48 weeks
CD4 should increase at 100 cells/mm3 each year of treatment and then stabilizes |
|
|
Term
What measures should be taken after HIV virilogic failure? |
|
Definition
Conduct genetic and phenotype testing of virus and replace old agents with new agents |
|
|
Term
This NRTI should not be given with aluminum antacid buffers due to chelation, like with FQ and tetracycline. |
|
Definition
|
|
Term
Describe the drug interaction with NNRTI. |
|
Definition
They have a net CYP 3A4 induction |
|
|
Term
CYP ___and __ can be inhibited by protease inhibitors. |
|
Definition
|
|
Term
___ is a UGT1A1 substrate (interacts with inducers and inhibitors) |
|
Definition
|
|
Term
What interactions are seen with Maraviroc and Cobicistat? |
|
Definition
Maraviroc = CYP3A substrate (interacts with inducers and inhibitors)
Cobicistat = CYP3A4 inhibitor |
|
|
Term
Lactic acidosis and severe hepatomegaly with steatosis are serious ADR of ____ |
|
Definition
NRTI - especially Stavudine and Zidovudine |
|
|
Term
Hypersensitivity syndrome and increased MI risk in some studies are serious ADR of ____ |
|
Definition
|
|
Term
Peripheral neuropathy and pancreatitis are serious ADR of ____ |
|
Definition
|
|
Term
Hepatotoxicity and severe allergy (Steven-Johnson’s syndrome) are serious ADR of ____ |
|
Definition
Nevirapine - do not give if healthy; 3A4 inducer |
|
|
Term
Neutropenia and severe anemia are serious ADR of ____ |
|
Definition
|
|
Term
Name the 4 types of endocrinological side effects seen with ART. They are common with ____ class of ART. |
|
Definition
1. Insulin resistance
2. Lipodystrophy syndrome
3. Osteoporosis/ Avascular necrosis
4. Dyslipidemia |
|
|
Term
The two types of statin that should be avoided during HIV treatment are. |
|
Definition
Simvastatin and Lovastatin |
|
|
Term
These 3 protease inhibitors have good lipid profile. |
|
Definition
Darunavir, Atazanavir, and Raltegravir (DAR) |
|
|
Term
|
Definition
Candida albicans infection |
|
|
Term
|
Definition
Pneumocystis jirovecii pneumonia |
|
|
Term
|
Definition
pneumocystic jirovecii - a fungi |
|
|
Term
|
Definition
|
|
Term
|
Definition
Cotrimoxazole (Bactrim) 1 tablet daily or Dapsone or Inhaled pentamidine |
|
|
Term
|
Definition
Stop prophylaxis when CD4+>200 cells/mm3 x 3 months |
|
|
Term
What is the treatment for pneumocystic jirovecii pneumonia? |
|
Definition
a. Cotrimoxazole (high-dose x 21 days)
b. Add 21-day course of corticosteroids if PaO2<70 |
|
|
Term
|
Definition
Can occur any time in HIV patients |
|
|
Term
|
Definition
|
|
Term
|
Definition
Oral Fluconazole
a. Topical therapy can be used for oropharyngeal only (clotrimazole, nystatin, miconazole) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Prophylaxis to all patients with CD4+<100 cells/mm3
Preferred: Cotrimoxazole DS 1 tablet daily |
|
|
Term
|
Definition
|
|
Term
|
Definition
No primary prophylaxis for CMV;
Secondary prophylaxis:
Ganciclovir or Valganciclovir
Alternatives: Foscarnet or Cidofovir
Lifelong unless immune reconstitution occurs (CD4+>100 cells/mm3 x 3 months) |
|
|
Term
|
Definition
1. Prophylaxis if CD4+ < 50 cells/mm3 |
|
|
Term
|
Definition
Prophylaxis if CD4+ < 50 cells/mm3
Preferred agents
1) Azithromycin 1200mg q week
2) Clarithromycin 500mg BID (more drug interactions)
b. Discontinue if CD4+ > 100 cells/mm3 x 3 months |
|
|
Term
|
Definition
Discontinue if CD4+ > 100 cells/mm3 x 3 months |
|
|
Term
|
Definition
Clarithromycin or Azithromycin + Ethambutol + consider Rifabutin (minimum of 12 months)
2-drug chronic maintenance therapy until CD4+ > 100 cells/ mm3 x 3 months |
|
|
Term
|
Definition
|
|
Term
|
Definition
a. Hepatitis B
b. Influenza annually (not intranasal)
c. Pneumococcus (1 or 2 shots depending on CD4+) |
|
|
Term
|
Definition
|
|
Term
|
Definition
a. Defined as >10% weight loss + symptoms
Treatment options
1) Appetite stimulants
a) Megesterol
b) Dronabinol
2) Anabolic agents
a) Testosterone
b) Anabolic steroids
3) Cytokines (cyproheptadine) |
|
|
Term
|
Definition
|
|
Term
What is Immune Reconstitution Inflammatory Syndromes (IRIS)? |
|
Definition
1. Refers to a group of clinical syndromes associated with immune recovery or reconstitution 2. Most commonly occurs is the setting of mycobacterial infections (MAC or Tuberculosis) 3. No precise definition but usually associated with worsening symptoms of the underlying opportunistic disease or unmask new sites 4. Occurs within 4-8 weeks usually
|
|
|
Term
Name 2 opportunistic infections that occurs often when CD4+ <50. |
|
Definition
Cytomegalovirus infection and Mycobacterium Avium Complex |
|
|
Term
2 Opportunistic infections that do not require primary prophylaxis |
|
Definition
Candida albicans and Cytomegalovirus |
|
|
Term
2 Opportunistic infections that are treated with Cotrimoxazole |
|
Definition
Pneumocystis jirovecii pneumonia and Toxoplasma gondii encephalitis
|
|
|
Term
Explain the immune response to influenza infection. |
|
Definition
- T-helper cells (mostly CD4+) activate macrophage
- Alveolar macrophage ingest and destroy >90% of bacteria
- Remaining bacteria multiply in the macrophage and are released upon cell death
- Released bacteria attract additional macrophage/monocytes. These form granulomas to “wall off” the infection and initiate bacterial clearance
|
|
|
Term
Give 4 differences between latent and active TB infection. |
|
Definition
· No symptoms
· TST or IGRA positive
· Normal chest radiograph
· If performed, respiratory smear and culture are negative
· One or more symptoms present
· TST or IGRA usually* positive
· Typically* abnormal chest radiograph
Respiratory smear and culture usually |
|
|
Term
Give the 5 diagnostic methods for tuberculosis. |
|
Definition
1. Test for acid-fast bacilli in tissue or fluid sample (typically sputum)
2. Culture and sensitivity testing (very slow-growing)
3. Tuberculin skin test (TST)
- Persons with no risk factors: >15 mm
- Persons at risk and recent immigrants: >10 mm
- HIV positive, organ transplant, other immunosuppression: >5 mm
4. Interferon gamma release assay (IGRA)
5. Chest radiography |
|
|
Term
Give the 2 recommended therapy for latent TB infection and monitoring parameters. |
|
Definition
Isoniazid Monotherapy - 300 mg PO daily x 9 months
· Isoniazid- Rifapentine DOT - 900 mg of each x 3 months (12 weeks) |
|
|
Term
Give the treatment and duration for active TB infection. What change should you make for HIV patients? |
|
Definition
· Initial Phase: isoniazid, rifampin, pyrazinamide, ethambutol daily for 2 months
· Continuation Phase: isoniazid and rifampin daily for 4 months
HIV = replace Rifampin with Rifabutin and give for 9 months |
|
|
Term
How do you combat TB patients with multi-drug resistant TB? |
|
Definition
· Requires individualized therapy with at least four (4) drugs with either certain or almost certain effectiveness
o Start with group 1 agents
o Add an injectable agent for 6 mos (group 2)
o Progress to groups 3 and 4 as needed
· Use daily dosing based on patients body weight
Treat for at least 18 months after culture negative |
|
|
Term
Give the monitoring parameters for the 1st line agents for active TB infection. |
|
Definition
o Isoniazid
o MOA: a prodrug; gets converted by mycobacterial catalase-peroxidase (to active metabolite to INH-NAD adduct and inhibits the biosynthesis of mycolic acids and blocks formation of cell wall by blocking the enzyme enoyl ACP reductase.
o ADR:
§ Antagonist of vitamin B6 (pyridoxine), so take supplements.
§ Hepatoxicity due to inhibition of CYP2E1.
§ Peripheral neuritis, esp. in slow acetylators, anemic or poor nutrition.
§ CNS problems: seizures in high dose, memory impairment, slurred speech and lethargy.
§ Anemia and dermatological effects
o Rifampin
o MOA: Rifampin blocks transcription (DNA to mRNA) by interacting with the β-subunit of mycobacterial DNA-dependent RNA polymerase, which suppresses initiation of the new mRNA chain.
o ADR:
§ CYP3A4 induction
§ some hepatitis
§ liver failure
§ flu-like syndrome
§ change contact lense and urine color.
o Pyrazinamide
o MOA: a prodrug that must be hydrolyzed to pyrazinoic acid for activity. It blocks mycobacterial fatty acyl synthase involved in mycolic acid synthesis (cell wall component).
o ADR:
§ Hepatoxicity
§ Gout due to reduced urate excretion
§ Arthralgia and dysuria etc.
o Ethambutol
o MOA: Blocks cell wall synthesis by inhibiting arabinosyl transferase.
o ADR:
§ Eye toxicity: optic neuritis and reduced visual acuity.
§ Gout due to reduced urate excretion
§ Rash and fever |
|
|
Term
Repeat culture and sensitivity for tuberculosis every ____ |
|
Definition
|
|
Term
Give the 4 types of diagnostic test for malarial infection. Which is the gold standard? |
|
Definition
· Blood smears (gold standard): q12-24 h for 3 consecutive days
· PCR (DNA & RNA probes), rapid dipstick tests, OptiMAL |
|
|
Term
Give the 3 antimalarial agents that can be given to a last minute traveler? When should they take these agents? |
|
Definition
Atovaquone-Proguanil
Primaquine
Doxycycline |
|
|
Term
Which 2 antimalarial agents should not be given to a last minute traveler? |
|
Definition
Chloroquine (1-2 weeks prior) and Mefloquine (>2 weeks prior) |
|
|
Term
Which antimalarial agent should not be given if CrCL is <30ml/min? |
|
Definition
Atovaquone-Proguanil (Malarone) |
|
|
Term
Which antimalarial agent can cause psychiatric, seizure, abnormal cardiac conduction? |
|
Definition
|
|
Term
Sun exposure should be avoided with this antimalarial agent. |
|
Definition
|
|
Term
Which antimalarial agent can cause G6PD deficiency and hemolytic anemia? |
|
Definition
|
|
Term
Which antimalarial agents can be taken if pregnant? |
|
Definition
Chloroquine and Mefloquine |
|
|
Term
Which antimalarial agents should be taken with food or milk to prevent nausea and abdominal pain. |
|
Definition
Atovaquone-Proguanil and Primaquine |
|
|
Term
Give the treatment regimen for Uncomplicated malaria/P. falciparum or unknown spp. |
|
Definition
§ Chloroquine
§ HydroxychloroquineAtovaquone-proguanil (Malarone®)
§ Quinine + (doxycycline or tetracycline or clindamycin)
Mefloquine (Lariam®) |
|
|
Term
Give the treatment regimen for Uncomplicated malaria/P. malariae or P knowlesi. |
|
Definition
§ Chloroquine
§ Hydroxychloroquine
|
|
|
Term
Give the treatment regimen for Uncomplicated malaria/P. vivax or P. ovale. |
|
Definition
Primaquine + Choroquine or Hydrochloroquine |
|
|
Term
Give the treatment regimen for chloroquine-resistant uncomplicated malaria/P. vivax. |
|
Definition
Primaquine + Atovaquone-Proguanil or Mefloquine or Quinine + Doxycycline or tetracycline |
|
|
Term
Give the treatment regimen for severe malaria. |
|
Definition
IV Quinidine + Doxycycline or tetracycline or Clindamycin
|
|
|